Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2009-05-22

Genetic Analysis of Ribosome Stalling and Rescue
Douglas Ray Tanner
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Biochemistry Commons, and the Chemistry Commons

BYU ScholarsArchive Citation
Tanner, Douglas Ray, "Genetic Analysis of Ribosome Stalling and Rescue" (2009). Theses and
Dissertations. 2272.
https://scholarsarchive.byu.edu/etd/2272

This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more
information, please contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

GENETIC ANALYSIS OF RIBOSOME STALLING AND RESCUE

by
Douglas R. Tanner

A dissertation submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree of

Doctor of Philosophy

Department of Chemistry and Biochemistry
Brigham Young University
August 2009

BRIGHAM YOUNG UNIVERSITY

GRADUATE COMMITTEE APPROVAL

of a dissertation submitted by
Douglas R. Tanner
This dissertation has been read by each member of the following graduate
committee and by majority vote has been found to be satisfactory.

Date

Allen R. Buskirk, Chair

Date

Barry M. Willardson

Date

Gregory F. Burton

Date

William R. McCleary

Date

Joel S. Griffitts

BRIGHAM YOUNG UNIVERSITY

As chair of the candidate’s graduate committee, I have read the dissertation of
Douglas R. Tanner in its final form and have found that (1) its format, citations,
and bibliographical style are consistent and acceptable and fulfill university and
department style requirements; (2) its illustrative materials including figures,
tables, and charts are in place; and (3) the final manuscript is satisfactory to the
graduate committee and is ready for submission to the university library.

Date

Allen R. Buskirk
Chair, Graduate Committee

Accepted for the Department
Date

David V. Dearden
Graduate Coordinator

Accepted for the College
Date

Thomas W. Sederberg
Associate Dean
College of Physical and Mathematical Sciences

ABSTRACT

GENETIC ANALYSIS OF RIBOSOME STALLING AND RESCUE

Douglas R. Tanner
Department of Chemistry and Biochemistry
Doctor of Philosophy

In eubacteria, ribosome stalling on broken messenger RNA transcripts
can lead to cell death. The trans-translation quality control mechanism
rescues many of these stalled ribosomes. In this process, tmRNA enters
stalled ribosomes by mimicking a transfer RNA, accepting the stalled nascent
peptide. The ribosome then releases the broken mRNA and resumes
translation on a coding region within tmRNA itself. Translation of tmRNA
marks the nascent peptide for destruction by the addition of a short
proteolysis tag and the ribosome is released at a stop codon within the
tmRNA open reading frame.
An intriguing aspect of trans-translation is that the ribosome
synthesizes one protein from two RNA templates. How is the proper site
chosen on tmRNA to resume translation? Do the conserved pseudoknot
structures help set the reading frame? Using a genetic selection to assay
libraries of tmRNA mutants, we found that stable hairpin structures can

functionally replace pseudoknot 1. We conclude that the role of pseudoknot
1 in tmRNA function is purely structural. Our results demonstrate that the
inactivity of an RNA mutant designed to destroy a given structure should not
be interpreted as proof that the structure is necessary for RNA function. Such
mutations may only destabilize a global fold that could be formed equally
well by an entirely different, stable structure.
Broken mRNAs are not the only cause of ribosome stalling; stalling can
also result from nascent peptide interactions with the ribosomal exit tunnel
that inhibit peptidyl-transferase activity. SecM, TnaC, and ErmCL all stall
ribosomes to regulate the expression of downstream genes. What other
peptide sequences can cause ribosome stalling? We modified our tmRNAbased selection to screen libraries of random peptides and identified a
number of novel stalling peptides, including the sequence FxxYxIWPP. This
sequence interacts with the exit tunnel differently than SecM and TnaC as
seen in studies using mutant ribosomes. Like SecM, stalling occurs on this
sequence with the next aminoacyl tRNA trapped in the A site but unable to
react with the nascent peptide. These results show that a variety of peptides
can interact in the exit tunnel and peptidyl-transferase center to regulate
ribosome activity.
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CHAPTER 1: INTRODUCTION TO RIBOSOME STALLING AND RESCUE

Ribosomes are large macromolecular complexes that catalyze the
synthesis of every protein in a cell. Cells cannot live without properly
functioning ribosomes. In fact, many antibiotics kill bacteria by binding to the
bacterial ribosome and preventing proper protein synthesis. Through their
central role in the expression of genetic information, ribosomes also participate in
the regulation of a number of genes involved in various other aspects of protein
synthesis.
The study of these essential protein synthesis machines has had significant
impact on molecular biology. For example, our understanding of the role of
mRNA and tRNA in protein synthesis was born of ribosome research (1). The
recent determination of the atomic structure of ribosomes has taught us much
about RNA structure. Many RNA structures in the ribosome have not been
observed in any other context (2). Studying ribosomes has also answered many
questions about the mechanism of antibiotic action as well as antibiotic
resistance. Approximately 40% of antibiotic drugs target components of the
ribosome or translation factors (3). Some antibiotics stall translation by binding
to the catalytic peptidyl-transferase center while others do so by blocking the
binding site of incoming tRNAs. Certain ligands, essential for translation, are
also targeted by antibiotics to prevent them from assisting with the steps of
translation.
Despite these notable fruits of ribosome research and the fundamental
cellular roles of the ribosome, there are still many aspects of ribosome function
yet to be explored. Our research focuses on two of these aspects, ribosome
1

stalling and the rescue of stalled ribosomes. Following a general review of
ribosome structure and function, these processes will be described in detail.

RIBOSOME STRUCTURE
Ribosomes are nearly 200 Å in diameter and have a mass of ~2.5
megadaltons. A fully functional prokaryotic ribosome is assembled from two
subunits to form a 70S complex. The larger of the two subunits, the 50S, is
composed of over 30 proteins and two ribosomal RNAs (rRNAs), a short 5S RNA
and the much longer 23S RNA (2904 nucleotides long). The smaller, 30S, subunit
is made up of ~20 proteins and a 1542 nucleotide (nt) 16S RNA (4) (Figure 1-1).
The rRNAs adopt complex structures that are stabilized by the ribosomal
proteins; these proteins are mostly located on the surface of the ribosome.
The two subunits in a 70S ribosome play different roles in translation. The
50S subunit is primarily responsible for peptide synthesis and contains the
peptidyl-transferase center (PTC) where peptide bonds are formed. It also

Figure 1-1. Crystal structure of
the Thermus thermophilus 70S
ribosome with bound tRNAs.
The 50S subunit is composed of
5S rRNA (cyan), 23S rRNA and
proteins (bright and pale
yellow, respectively). The 30S is
formed with the 16S rRNA and
proteins (bright and pale
orange, respectively). The A, P,
and E-site tRNAs are green, red,
and blue, respectively. (PDB
acc. 2J01, 2J02) (4).
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contains a region known as the GTPase associated center (GAC) where proteins
bind to order and regulate the steps in translation. The 30S subunit selects
proper tRNAs. This subunit contains a decoding center where tRNAs are paired
with or “decode” mRNAs. This region binds mRNA and monitors the tRNAs
entering the ribosome to ensure they are cognate or complementary to the
mRNA. At the interface of the two subunits are three tRNA binding sites; the A
or aminoacyl site, where aminoacylated tRNAs enter the ribosome; the P or
peptidyl site, where the peptidyl-tRNA is bound; and the E or exit site, where
deacylated tRNAs are held until they can be ejected from the ribosome. tRNAs
bound in these sites interact with both subunits simultaneously.

RIBOSOME FUNCTION
Ribosomes synthesize proteins in a three-step process of initiation,
elongation, and termination (5, 6). During initiation, individual 30S and 50S
subunits combine on an mRNA to form active 70S ribosomes. Then elongation
ensues, where with the help of tRNAs and protein cofactors, the ribosome builds
polypeptide chains one amino acid at a time. When a ribosome reaches a stop
codon, release factors and recycling factors are recruited to terminate translation.
Termination releases the newly synthesized polypeptide and then the subunits
dissociate. These subunits are recycled and begin the translation process again
on another transcript. Each of these steps is described below.

Initiation
The ribosomal subunits must be assembled properly at the right site on an
mRNA to ensure correct frame selection. This alignment is achieved through the
3

interaction of a free 30S subunit with a consensus sequence in the mRNA called a
Shine-Dalgarno sequence or ribosome-binding site (RBS). In an mRNA, the RBS
(consensus AGGAGG in E. coli) is complementary to the 6 nt at the 3′ end of the
16S rRNA and is positioned ~7 nt upstream of an initiation codon (usually AUG).
Because of this spacing, the AUG codon is positioned in the P site of the
ribosome when the RBS and rRNA are paired. This 30S-mRNA interaction is an
essential part of initiation in prokaryotes.
Also essential for initiation is the binding of a specialized tRNA and the
50S subunit to the 30S-mRNA complex. These binding interactions are
coordinated by three initiation factor proteins, initiation factor (IF) 1, 2, and 3.
The specialized tRNA, a formylated methionyl-tRNA (fMet-tRNA), is aligned
with the mRNA start codon in the P site with the help of IF-2. IF-2 binds to fMettRNA and delivers it to the 30S subunit where it is tightly associated. IF-1
associates with the 30S subunit and blocks tRNAs from accessing the A site. IF-3
binds the 30S on the other side of fMet-tRNA, in the region of the E site, to
prevent premature association of the 50S subunit. When the fMet-tRNA and
initation factors are properly associated with the 30S subunit, IF-3 is released
from the ribosome and the 50S subunit binds. 50S binding triggers GTP
hydrolysis by IF-2, resulting in the release of IF-1 and IF-2 from the complex. A
70S ribosome is now completely assembled on the mRNA. It has a bound P-site
fMet-tRNA and an empty A site and is ready to begin elongation.

Elongation
Following formation of the 70S initiation complex, tRNAs are selected and
incorporated in the process of elongation. Elongation of a polypeptide takes
4

place in a repetitive cycle of tRNA selection, peptidyl transfer, and translocation.
During tRNA selection, many different aminoacyl-tRNAs diffuse into the A site;
these tRNAs are part of a ternary complex with the elongation factor (EF)-Tu and
GTP. EF-Tu•GTP binds to the aminoacylated 3′ end of tRNAs to protect the
amino acid from forming peptide bonds prematurely. The 30S subunit monitors
these entering aminoacyl-tRNAs for proper base pairing between the mRNA
codon in the A site and the anticodon loop on tRNA. In E. coli, the codons for
each of the 20 natural amino acids are “decoded” by 49 different tRNAs (7), each
with a unique anticodon sequence; proper codon-anticodon pairing ensures the
addition of the correct amino acid to the polypeptide chain. The 30S subunit
monitors these interactions through the movement of two adenine residues,
A1492 and A1493, in helix 44 of the 16S RNA (Figure 1-2). When a non-cognate
tRNA is in the ribosome, these residues are sequestered in an internal loop of the
helix. When a cognate tRNA pairs with the mRNA, however, these bases flip out
of the helix and interact with the minor groove of the codon-anticodon pair (4, 8).
The repositioning of A1492 and A1493 in response to selection of a tRNA
transmits a signal from the 30S subunit to the GTPase associated center in 50S
Figure 1-2.
Conformation of A1492
and A1493 when the
correct tRNA decodes
the A-site codon.
Bases 1492 and 1493 of
16S RNA flip out of helix
44 (orange) when a
correct codon:anticodon
interaction is made. The
red and blue residues
are a representative base
pair of a tRNA (red) that
correctly decodes an Asite codon (blue) (PDB
acc. 2J01, 2J02) (4).
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subunit. This signal triggers EF-Tu hydrolysis of GTP and its dissociation from
the ribosome, which, in turn, allows the aminoacyl-tRNA to rotate into a position
where it is fully accommodated. Failure of a mismatched tRNA to alter the
conformation of A1492 and A1493 prevents GTP hydrolysis and leads to its
rejection by the ribosome.
After accommodation of the correct tRNA, the peptidyl-transferase center
catalyzes the transfer of the nascent polypeptide from the P-site tRNA to the
amino group on the A-site tRNA. The ribosome catalyzes amide bond formation
in two ways. First, it catalyzes the reaction through entropic reduction by closely
positioning the conserved 3′ CCA stem of the A- and P-site tRNAs, which are
attached to the amino acid directly. Secondly, the ribosome positions the 2′-OH
of A76 on the P-site tRNA so that the hydroxyl can shuttle protons in the reaction
(9). Once the peptide has been transferred to the A-site tRNA, the P-site tRNA is
uncharged and the ribosome is poised for translocation.
Translocation is the rearrangement that prepares the ribosome to select a
new tRNA after peptidyl transfer. During translocation, the ribosome moves on
the mRNA by one codon in the 5′ to 3′ direction. This repositions the mRNA and
tRNAs within the ribosome. The A-site tRNA, now linked to the polypeptide,
moves to the P site and the deacylated P-site tRNA advances to the E site. This
movement is driven by GTP hydrolysis on EF-G, an elongation factor which
binds to the ribosome following peptidyl transfer (10, 11). After translocation,
EF-G•GDP dissociates from the ribosome, leaving an empty A site and the
peptidyl-tRNA in the P site. Peptide elongation continues cycling through this
three-step process of tRNA selection, peptidyl transfer, and translocation one
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codon at a time until a stop codon is positioned in the A site. This signals the end
of elongation and the beginning of termination.

Termination and Ribosome Recycling
At a stop codon, the nascent peptide is released and the ribosome
dissociates. In order for a nascent peptide to be released from the ribosome, the
ester bond between the peptide and the P-site tRNA must be cleaved. This ester
bond is hydrolyzed by a class I release factor, either RF1 or RF2. These proteins
are specifically recruited by different stop codons; RF1 binds to UAG, while RF2
recognizes UGA stop codons in a similar manner (12). Both bind to UAA. Class
I release factors free the nascent peptide by specifically positioning a water
molecule to attack the ester. This molecule is held in place by a conserved GGQ
motif in these enzymes (13). Hydrolytic release of the peptide allows the class II
release factor, RF3, to bind to RF1 or RF2 and release them from the ribosome.
The ribosomal subunits are then dissociated through the action of ribosomal
release factor (RRF) in conjunction with EF-G.

RIBOSOME STALLING
Failure of the ribosome to properly carry out any of the steps in elongation
or termination leads to ribosome stalling. Often, ribosome stalling is due to
damaged mRNAs. It can also be caused by insufficient levels of tRNAs. In such
cases, stalling is not caused by problems with the ribosome but problems with its
ligands. Ribosome stalling can also be caused directly, where ribosome function
is inhibited; it is incapable of translation even in the presence of all the necessary
components. Many antibiotics can directly prevent ribosome function and,
7

surprisingly, a handful of nascent peptide sequences are also capable of arresting
ribosome function directly. Many of these peptides use ribosome stalling as a
means for regulating gene expression. We will first present a few examples of
indirect stalling, then direct stalling caused by stalling peptides and antibiotics
will be discussed in detail.

Indirect Ribosome Stalling
One cause of indirect ribosome stalling is the lack of a stop codon on an
mRNA transcript. A non-stop mRNA is generated when RNA polymerase falls
off a transcript prematurely or when exonucleases degrade its 3′ end, including
the stop codon. When a ribosome translates to the end of an mRNA without
encountering a stop codon, it is arrested, waiting for a release factor. Without a
stop codon, however, a class I release factor cannot enter the ribosome to release
the nascent peptide that is bound to the P-site tRNA. Stalling on non-stop
mRNAs is common in prokaryotic cells because translation begins on an mRNA
while it is still being transcribed. Because transcription and translation are
coupled, there is no mRNA quality-control step prior to translation. In
eukaryotes, in contrast, ribosomes only begin translation in the cytoplasm
following completion of several mRNA processing steps including splicing,
addition of a 5′ cap, and polyadenylation of the 3′ terminus. Although
eukaryotes do have safeguards against translating non-stop mRNAs, eukaryotic
ribosomes do occasionally reach the 3’ end of a transcript without encountering a
stop codon. When this happens, a process known as “nonsense decay” is
activated and the ribosome bound mRNA is rapidly degraded by a number of
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exonucleases that form an exosome (14, 15).
Certain cellular conditions can also lead to ribosome stalling. A shortage
of a given charged aminoacyl-tRNA, for example, can result from either amino
acid starvation or the depletion of the tRNA itself. The E. coli genome contains a
number of codons which are not highly represented. These rare codons are not
often found in highly expressed genes. Often the tRNAs that decode rare codons
are only expressed at low levels as well. When a rare codon is positioned in the
A site but no cognate tRNAs are available, the ribosome pauses, waiting for the
tRNA. The shortage of a particular amino acid leads to stalling for the same
reasons as tRNA shortage. Low levels of an amino acid such as alanine, for
example, result in shortages of alanyl-tRNAAla. When the ribosome reaches an
Ala codon, translation is paused until alanyl-tRNAAla is accommodated. If there
is little available, then this pause may be quite long. In these situations,
accommodation of the proper tRNA even after a prolonged pause can return the
ribosome to full function. This indirect type of stalling is due to a lack of
resources and is not related to direct inhibition of the ribosome itself.

Stalling Through Direct Means
A small number of nascent peptide sequences have been identified which
directly prevent translation by interacting with specific regions of the ribosome.
Three regions have been identified which play a major role in arresting ribosome
function: the A site, the peptidyl-transferase center, and the exit tunnel for the
nascent peptide. Interactions of charged tRNAs or free amino acids with the A
site, in combination with nascent peptide interactions with the exit tunnel or
PTC, can arrest the ribosome by inhibiting its peptidyl-transferase activity.
9

Three prokaryotic peptides, SecM, ErmCL, and TnaC, illustrate how
nascent peptides, together with accessory molecules, can interact with each of
these regions to inhibit peptidyl transfer. Each is a short leader peptide that
regulates the expression of a downstream gene. This regulation is usually
mediated through an mRNA attenuator hairpin. An attenuator is an RNA
structure capable of either allowing or attenuating gene expression in response to
a cellular signal. In these examples, the signal that regulates attenuation is
ribosome stalling. Unless the ribosome stalls on the leader peptides, expression
of the regulated genes is attenuated, or prevented. When the ribosome stalls,
however, a change in RNA conformation allows the expression of the
downstream gene. All three peptides, SecM, ErmCL, and TnaC, cause stalling
through slightly different interactions with the ribosome, but each stalling event
effectively regulates attenuation (16-18). After a brief look at the biological role
of each of these regulatory peptides, we will look at the mechanism by which
they inhibit ribosome function.

Biological Relevance of Regulatory Stalling
In E. coli, the secretion monitor (SecM) protein regulates the expression of
secA, part of the secretory machinery. SecM contains a signal sequence, which, if
the secretion machinery is functioning efficiently, allows the SecM peptide to be
pulled out of the ribosome (18, 19). The ribosome always stalls when translating
SecM, but if the concentration of SecA is high, the stall-inducing peptide is
quickly pulled from the ribosome and translation continues. Rapid clearance of
the stalling peptide favors the attenuation of secA expression. When the
ribosome stalls on SecM and levels of SecA are low, however, the stalled
10

ribosome remains arrested. This stalling event alters the mRNA structure,
increasing translation of secA.
ErmCL is a second leader peptide that uses ribosome stalling to turn on
the expression of an attenuated gene (16, 20). As with SecM, ribosome stalling on
ErmCL prevents attenuation. In this case, the regulated gene, ermC, encodes a
methylase that confers cellular resistance to the antibiotic erythromycin.
Ribosomes stall while translating ErmCL in cells that have been exposed to
sublethal levels of erythromycin, but they do not stall on the peptide in the
absence of erythromycin. In this way, the resistance gene is only expressed when
it is needed by the cell.
The third example of a regulatory stalling peptide is TnaC (17, 21). This
leader regulates the expression of tnaA. tnaA encodes tryptophanase, an enzyme
that breaks down tryptophan. Ribosome stalling on TnaC is dependent upon
cellular levels of free tryptophan (Trp). When levels of Trp are high, free Trp
binds in the A site of the ribosome and causes stalling on TnaC. Ribosomes
stalled on TnaC prevent attenuation of tnaA expression, resulting in increased
levels of tryptophanase. When Trp levels are low, tryptophanase is not needed
and the ribosome does not stall on TnaC. Proper termination of TnaC without
stalling allows attenuation of tnaA expression, lowering tnaA expression.

How do these Peptides Cause Stalling?
All three of these stalling peptides inhibit the peptidyl-transferase activity
of the ribosome. This has been determined through use of the antibiotic
puromycin to study stalled ribosomes. Puromycin, a structural mimic of
aminoacylated tRNA, can bind to the A site of ribosomes. When bound in the A
11

site, puromycin acts as a peptide acceptor. Following peptidyl transfer to
puromycin, however, the antibiotic does not remain associated with the
ribosome. This results in the premature release of the nascent peptide. If the
peptidyl-transferase activity of the ribosome is inhibited, then the nascent
peptide will not be transferred to puromycin and it will remain bound to the Psite tRNA in the ribosome. The conclusion that ErmCL, SecM, and TnaC inhibit
the peptidyl-transferase activity of the ribosome is based on the observation that,
when stalled, none of these peptides is transferred to puromycin. Likewise, none
of these peptides is transferred to the next amino acid or release factor in the
wild-type context (16, 21, 22).
Although it is clear that ErmCL, SecM, and TnaC cause stalling by
inhibiting the peptidyl-transferase activity of the ribosome, how they do this is a
more difficult question to answer. The sequence of each peptide is quite
different as are the cellular conditions that allow stalling in each context. But,
despite these differences, each interacts with the peptide exit tunnel and the PTC.
Stalling on SecM and TnaC is also supported by binding of specific ligands in the
A site. While ErmCL also interacts with the exit tunnel and PTC it does not
appear to have specific A-site requirements.

The Sole of the A Site in Stalling
The A-site substrate plays a role in stalling on SecM and TnaC. Stalling on
SecM occurs during the elongation step of translation with the peptidyl tRNA
bound to the P site and a prolyl-tRNAPro in the A site. Although this proline
(Pro166) is not incorporated into the nascent peptide, its identity is essential for
stalling. Replacing Pro166 with alanine abolishes stalling on SecM. This
12

suggests that the prolyl-tRNAPro makes specific interactions with the A site of the
ribosome to contribute to stalling.
Like SecM, TnaC also shows notable sensitivity to the A site substrate.
TnaC stalls during termination in the presence of high levels of free tryptophan.
Translation of TnaC causes the A site of the ribosome to adopt a conformation
that binds free Trp (23). The binding of Trp to the PTC inhibits RF2-mediated
peptidyl transfer to water and subsequent peptide release (21). Replacing the
stop codon (UGA) of TnaC with a tryptophan (Trp25) leads to constitutive
stalling on TnaC, independent of free tryptophan levels. But replacing the stop
codon with a proline instead of tryptophan abolishes stalling (17). The encoded
tryptophanyl-tRNATrp appears to interact with the A site in the same way as free
Trp. It is clear from this finding that stalling on TnaC is highly sensitive to
changes in the A site.
Unlike these examples, stalling on ErmCL is independent of A-site
interactions. ErmCL stalls during elongation with the nascent peptide bound to
the P-site tRNA, but the A-site tRNA does not contribute to this stalling event.
The efficiency of ribosome stalling on the wild-type ErmCL sequence, with SertRNA in the A site, is no different from the efficiency of stalling on a mutant
peptide with alanine in place of serine (16). This is evidence that stalling on
regulatory peptides occurs through different mechanisms, one of which does not
rely as heavily upon the identity of the A-site substrate.

Regulatory peptides interact with the exit tunnel
In addition to the A site, the polypeptide exit tunnel also contributes to the
efficiency of stalling on regulatory peptides. This tunnel allows nascent
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Figure 1-3. Cross section of the 50S
subunit showing the peptide exit
tunnel.
The ribosome exit tunnel extends from
the peptidyl transfer center (PT, red) to
the outside boundary of the 50S subunit.
L4 and L22 (dark blue) protrude into the
tunnel to create a constriction where the
tunnel bends. A nascent peptide (gray)
must also bend at this constriction to
transit the tunnel. Reprinted with
permission from Nissen et al. (20).

peptides, as they are synthesized, to
travel from the PTC through the 50S
subunit ~100 Å to the outside
boundary of the ribosome (Figure 13). Assuming an extended
conformation, this is long enough to accommodate a polypeptide between 30 and
40 residues long (24). The exit tunnel is lined primarily with RNA, permitting
virtually all peptide sequences to pass through uninhibited (25, 26). It is because
of the inert nature of the exit tunnel that the ribosome can synthesize every
combination of amino acid sequences required to produce the proteins necessary
for life. There is one region of this tunnel, however, where two ribosomal
proteins protrude from opposite sides: these proteins, L4 and L22, form a narrow
constriction near the only bend in the tunnel (26). Although the exit tunnel is
quite inert, these regulatory peptides have been found to make specific contacts
with both protein and RNA residues in the tunnel. These interactions help
inhibit the peptidyl-transferase activity of the ribosome to cause ribosome
stalling.
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There is little homology between the stalling regions of the regulatory
stalling peptides. SecM is 170 amino acids long, but a region of only 17 amino
acids is sufficient to cause stalling: F150xxxxWIxxxxGIRAGP166 (18). In this and
each of the following peptides, only the residues specified are required for
stalling; the spacing between the essential residues must be maintained,
however, for maximum efficiency of stalling. The segment of TnaC that is
required for stalling (13 of its 24 amino acids) is quite different from that of SecM.
This sequence is W12xxxDxxxxxxxP24(UGA) (27). Regulation of ermC expression
only requires the first nine residues of the 19 amino acid leader peptide,
M1xxxxIFVI9 and erythromycin (16). Met1 cannot be mutated to another residue,
due to the need for a start codon in this position, so it is not clear if methionine is
essential for stalling. When modeled in the exit tunnel, however, the formylated
methionine of the nascent peptide appears to extend to the narrow region of the
exit tunnel where it could make specific contacts (16). The only major similarities
between the sequences are tryptophans Trp155 of SecM and Trp12 of TnaC and
the isoleucines Ile6 of ErmCL and Ile162 of SecM, which are found similar
distances from the PTC (16, 17).

SecM
TnaC
ErmCL

FxxxxWIxxxxGIRA G P
WxxxDxxxxxxx P *
MxxxxIFV I S

Table 1-1. Alignment of stalling peptide sequences.
The regions highlighted in green are near L4/L22
while those in blue are close to the PTC. The
underlined blue letters are located in the P site and the
underlined black letters are in the A site.
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Alignment of these peptides indicates that the position of the essential
residues may be more significant than their identity. The essential residues of
each stalling peptide are clustered in two regions. The first region is near the
L4/L22 constriction of the exit tunnel (Table 1-1). The second region consists of
the residues proximal to the P-site tRNA of the stalled peptides. These residues
are expected to interact with the ribosome in the region of the peptidyltransferase center rather than the L4/L22 region.
If ribosome stalling is dependent upon the identity of the nascent peptide
residues near the PTC and constriction of the exit tunnel, then there should also
be essential ribosomal residues in these same regions. Genetic screens on
libraries of mutant ribosomes have revealed that this is indeed the case. In fact, a
pattern of reactivity for each peptide has been identified that extends from the
constriction back to the PTC. Notably, however, each stalling peptide has a
different profile of interactions with the ribosome.
The constricted region of the exit tunnel is where the most mutations have
been identified that prevent stalling. A number of mutations in L22 can prevent
stalling on ErmCL, TnaC and SecM. The most significant L22 mutation that
relieves stalling on ErmCL and SecM is the deletion of Met82-Arg84 (ΔMKR) (16,
28). SecM stalling is also relived by Gly91Ala and Ala93Ser. Curiously, these
mutants have no effect on TnaC-induced stalling (29). Likewise, an interaction
unique to TnaC, Lys90, is absent in SecM and ErmCL stalling. An L22 Lys90Trp
mutation relieves stalling on TnaC, but SecM still stalls efficiently in its presence
(29). These differences support the hypothesis that each of these stalling
peptides functions through a slightly different mechanism from the others.

16

Despite these differences, however, it is clear that each peptide makes contacts
with this protein.
Among the 23S rRNA mutations that affect stalling near the constriction of
the exit tunnel are an A insertion at base 751, which relieves stalling on both
TnaC and SecM (29), and an A2058G mutation. The latter has notable and
variable affect on the stalling peptides. Stalling on ErmCL and SecM is
completely relieved by this mutation, whereas it actually increases the stalling
efficiency on TnaC (16, 29). Again, this evidence supports the hypothesis that the
PTC is regulated through interactions with distal regions of the tunnel.
Moving from the constriction towards the PTC, we find more points of
interaction between the rRNA and the stalling peptides. Among those with the
most notable impact on stalling efficiency in this region is U2609C. This
mutation completely abolishes stalling on TnaC (29). A second mutation in this
mid-region of the tunnel is residue U2062A. This was shown to relieve stalling
caused by the ErmCL peptide (16). The peptide interactions with this mid-region
of the tunnel are likely to work in concert with those at the more distal end of the
tunnel as well as at the PTC.
Although no stall peptides have been tested against mutations in the PTC,
as these are lethal, this region is certainly involved in peptide-mediated stalling.
The best evidence for this is the essential identity of the P-site substrate in each
stalling peptide. The identity of the residue in the P site is important in each
case, but it is notable that each is different: the P site of stalled TnaC has a Pro
while it this a Glycine in SecM and an Ile in ErmCL. The unique interactions of
each stalling peptide with the PTC, the mid-region and constricted region of the
exit tunnel are evidence that the ribosome can be stalled through different
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mechanisms. There are common patterns in each case, which likely involve a
network of interactions with the exit tunnel, but the differences are significant
enough to suggest that the ribosome can be regulated by a number of different
peptide sequences.
It is apparent that a network of peptide interactions with the exit tunnel
do contribute to stalling, but the constriction of the exit tunnel is ~ 25 Å away
from the PTC. How does this interaction regulate the PTC from such a distance?
It has been suggested that the nascent peptide can trigger a cascade of
conformational rearrangements in the rRNA, which allosterically regulate the
peptidyl transferase activity of the ribosome. This hypothesis is supported by
the work of Mitra et al. in which cryo-electron microscopy was used to visualize
structural differences between stalled and non-stalled ribosomes (30). The
stalled ribosomes were generated on a SecM transcript. Comparison of the
stalled and non-stalled ribosomes showed a dramatic rearrangement of rRNA
throughout the 23S rRNA. These changes included the rearrangement of
intersubunit bridges and the modification of the peptidyl-transferase region as
indicated by the repositioning of tRNAs bound to the ribosome (30).
Conformational changes in the peptidyl-transfer center have been
reported before. The Steitz lab determined the crystal structure of the large
subunit complexed with peptidyl-tRNA mimics. In the different conformational
states obtained with several analogs, it was found that rRNA bases U2585 and
U2506 are repositioned in an induced-fit mechanism upon correct binding of a
tRNA mimic (31). These bases protect the peptidyl-tRNA from hydrolysis by
water and must rotate to allow peptidyl transfer or peptidyl release by water
during termination. The two bases are among the four conserved bases in the
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Figure 1-4. Cross section of the 50S subunit showing potential signaling network.
Base A2058 (pink) in the exit tunnel is important for ribosome stalling. One potential
mechanism for signal transmission from A2058 to the PTC is through base-backbone
interactions with G2505 (green). Movement of G2505 would be transmitted to its adjacent
nucleotide U2506 (red). This is one of the inner shell bases (red) that is essential for peptide
bond catalysis in the ribosome (PDB Acc. 2AWB) (32, 33).

peptidyl transfer center known as the “inner shell” of nucleotides. The other
two, besides U2585 and U2506, are A2602 and A2451.
Building on these observations, Beringer has proposed a specific
mechanism for how peptides in the exit tunnel can regulate the PTC (33). The
base A2058 in the 23S RNA affects stalling of all three regulatory peptides. He
suggests that peptide interactions with this base transmit a signal to the PTC via
an intermediate base. Specifically, base 2058 interacts with the peptide backbone
of G2505. Movement of G2505 is directly transmitted to its “inner shell”
neighbor U2506 (Figure 1-4). As was noted by Steitz, U2506 must be
repositioned upon substrate binding in the A site in order to protect the ester
bond between the tRNA and nascent peptide (31). Disrupting the movement of
this or any of the other inner shell nucleotides may be sufficient to prevent
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peptidyl transfer. Though this signaling network has yet to be verified, it is
likely that such a cascade of RNA interactions is involved in regulating the PTC
from the essential residues of the exit tunnel.

Regulatory Peptides Interact with the PTC
In characterizing the nature of stalling on SecM and ErmCL, it was found
that extensive interactions with the exit tunnel are not necessary for stalling.
Using truncated versions of ErmCL (MSIFVI) and SecM (IRAGP) that are too
short to reach the constriction of the exit tunnel, stalling still has been observed,
though at a much lower efficiency (16, 34). Stalling on these sequences must be
due to interactions with different regions of the exit tunnel than are involved in
stalling on full-length peptides. It is likely that this interaction may even be
limited to the peptidyl-transferase center itself and not rely upon the exit tunnel.
A related phenomenon of stalling during termination compares to these short
peptides and supports the hypothesis that stalling can be caused through direct
interactions with the peptidyl-transferase center.
This unusual phenomenon involves ribosome stalling on the YbeL
protein. Unlike the other stalling events described, stalling on YbeL occurs at the
C-terminus of the full-length protein. YbeL is not a leader peptide and stalling
on the gene plays no known regulatory or other biologically significant role.
What is most notable about stalling on YbeL is not related to the gene itself, but
to the sequence that causes stalling: Glu-Pro-Stop. This dipeptide followed by a
stop codon has been found to cause stalling when added to the end of any gene.
Similar sequences, Asp-Pro-Stop and Pro-Pro-Stop, have also been shown to
cause ribosome stalling with high efficiency (35).
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How can ribosomes be stalled at termination by only two amino acids? It
has been shown that this is not an indirect stalling event caused by rare codons;
the identity of the Pro codon has no affect on the levels of stalling on Glu-ProStop. If stalling is caused directly by the peptide, any interactions between GluPro-Stop and the exit tunnel must be minimal; as in the case of IRAGP and
MSIFVI, stalling on Glu-Pro-stop would have to be the result of a more direct
interaction with the PTC. In support of this hypothesis is the finding that the
identity of the C-terminal amino acid proline is the key to this stalling event.
Replacing proline in the peptide with the structurally similar azetidine-2carboxylic acid decreased ribosome stalling markedly, whereas incorporation of
3,4 dehydroproline increased the level of ribosome stalling at termination (35). It
is probable that proline is interacting with the PTC to regulate its function.
Interestingly, in addition to the role proline may play in regulating the
PTC, it appears there are also A site requirements for this type of stalling. Early
studies of termination revealed that the efficiency of termination with a Cterminal Pro is affected by the identity of the release factor (36, 37). This
ribosome sensitivity to the A-site substrate during termination indicates that the
A site may still play a role in stalling on Glu-Pro-Stop.
The results of the Glu-Pro-Stop research combined with the analysis of
stalling on IRAGP and MSIFVI indicate that ribosomes can be stalled even
without exit tunnel involvement. It is likely that these also interact specifically
with the peptidyl-transferase center of the ribosome, but such a conclusion will
be difficult to confirm through mutational analysis. Many of the 23S RNA bases
in the region of the PTC are highly conserved; mutating these is often lethal.
Although in vivo systems using orthogonal ribosomes have been developed to
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study the effects of ribosome mutations, these have not yet been applied to
studies of PTC mutations (38). There are many questions about stalling caused
by interactions with the PTC that have yet to be answered.

Antibiotics Cause Ribosome Stalling
As was mentioned previously, many antibiotics kill cells by inhibiting
translation (3). Studying these effects of antibiotics on ribosome function may
help explain stalling on nascent peptides. Chloramphenicol and erythromycin
prevent peptide bond formation when bound to the ribosome. Chloramphenicol
does so by binding to A2451, a nucleotide in the inner shell of the peptidyl
transfer center. Erythromycin interacts with the exit tunnel near protein L22,
likely blocking the passage of the nascent peptide, but this mechanism is unclear
(39, 40). Other antibiotics inhibit translation by preventing tRNAs from
accessing the A site. Among these are tetracycline, which binds to the 16S RNA
to prevent general access of tRNAs, and streptomycin, which binds the 16S RNA
and specifically prevents fMet-tRNA from binding to the ribosome (1). The
interactions of each of these antibiotics with the ribosome give insight into what
ribosomal residues may be important points of interaction or signaling during
stalling on nascent peptides.
Regardless of how ribosome stalling is caused, whether by truncated
mRNAs, rare codons, regulatory stalling peptides, C-terminal prolines, or
antibiotics, the effect of this event can be very costly for a cell. Ribosome
synthesis requires significant input of cellular resources and energy. Often
several ribosomes are found translating a single transcript simultaneously;
stalling of just one of these ribosomes could prevent recycling of several others
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on the same transcript. To minimize the potentially lethal effects of high levels of
ribosome stalling, bacteria have evolved several mechanisms to free stalled
ribosomes. Among these are frameshifting (41), peptidyl drop-off (42) transtranslation(43). Although each of these may play a role in many stalling events,
we have focused only on trans-translation, which not only frees stalled ribosomes
but also destroys problematic peptides and mRNAs.

RIBOSOME RESCUE: TRANS-TRANSLATION
How does a cell rescue stalled ribosomes? Rather than creating a new
mechanism for termination and recycling, eubacteria have evolved a way to
reactivate translation by stalled ribosomes. This mechanism, known as transtranslation, is carried out through the unique functions of two molecules:
transfer-messenger RNA (tmRNA) and its protein cofactor small protein B
(SmpB). These molecules, which are conserved in all eubacterial genomes, allow
stalled ribosomes to be recycled through the canonical termination and recycling
mechanisms (reviewed in (43, 44)).
tmRNA rescues stalled ribosomes by acting first as a tRNA mimic then as
an mRNA. In the first step of trans-translation, alanylated tmRNA bound to
SmpB enters the A site of stalled ribosomes. The nascent peptide is then
transfered to the alanyl moiety of tmRNA and the peptidyl-tmRNA•SmpB
complex is translocated to the P site. During this translocation step the ribosome
actually switches templates: the stalled mRNA is ejected from the ribosome and
translation resumes on an open reading frame (ORF) in tmRNA (hence the name
trans-translation). Translation of the ORF of tmRNA adds a protease recognition
sequence to the C-terminus of the nascent peptide. At the end of the ORF is a
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stop codon that frees the ribosome and nascent peptide through the canonical
steps of termination and ribosome recycling. The aborted protein is then
degraded by cellular proteases such as ClpXP.

tmRNA Rescues Stalled Ribosomes
Fully processed E. coli tmRNA is 363 nucleotides long and consists of four
pseudoknots (pk1-4), a tRNA-like domain (TLD), and an open reading frame
(ORF) (45, 46). Pseudoknots are stable tertiary RNA structures composed of at
least two stem-loops in which one loop forms a stem with a second loop.
Pseudoknots 2-4 of tmRNA can be individually replaced with single stranded
RNA without destroying its function (47). Early studies of pseudoknot 1
reported that the structure was necessary for tmRNA function (48) but that
finding has been challenged in recent reports (49, 50). The ability of tmRNA to
function without specific pseudoknot structures suggests that they do not play a
role in trans-translation, but they are more likely involved in maintaining the
overall structure of tmRNA and protecting it from degradation (51). Unlike the
pseudoknots, the TLD and ORF of tmRNA are essential for tmRNA function.
Another essential component of the trans-translation system is the protein
SmpB (52). This 160 amino acid long protein (53) has a β-barrel core that binds to
the TLD of tmRNA (54). The TLD of tmRNA includes a T arm, D loop and
modified bases as well as the 3′ CCA amino acid acceptor stem (45, 46). SmpB
binding stabilizes the TLD of tmRNA, allowing its 3′ end to be recognized and
aminoacylated by alanyl-tRNA synthetase (53). SmpB also interacts with the
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ribosome. These interactions likely help the ribosome resume translation in the
proper frame on tmRNA (55, 56).
Even after tmRNA is bound by SmpB and alanylated, trans-translation
cannot begin until the ribosome is ready. The major requirement for tmRNA and
SmpB binding to stalled ribosomes is an empty A site (57, 58). The A site must
not only be free of tRNA, but it must also be free of mRNA. The efficiency of
tmRNA entry to the ribosome is directly related to the length of the mRNA. The
longer the 3′ end of an mRNA extends from the P site into the A site and beyond,
the less efficiently tmRNA is bound to the ribosome (34). The requirement for an
empty A site is automatically met in ribosomes stalled on non-stop mRNAs, but
when a ribosome is stalled on a full-length transcript, the mRNA must first be
cleaved before tmRNA can enter. The mRNA in stalled ribosomes is either
cleaved in the A site by an unidentified endonuclease or at the 3′ boundary of the
ribosome by exonucleases (58, 59). This cleavage event eliminates steric
constraints between the mRNA and the tmRNA•SmpB complex, allowing the
trans-translation machinery to access and act upon the stalled ribosome.
Once tmRNA is alanylated and the A site is cleared of mRNA, transtranslation may begin. This starts with tmRNA entry into the ribosome. The
aminoacylated TLD of tmRNA is recognized by EF-Tu, which delivers the
tmRNA•SmpB complex to the ribosome. Once the tmRNA•SmpB complex
enters the A site, it must bind the ribosome in a specific conformation that will
allow GTP hydrolysis then peptide bond formation.
How is a stalled ribosome induced to hydrolyze GTP in the absence of any
codon-anticodon interactions? There is no mRNA codon for tmRNA to
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recognize in the A site; tmRNA does not even contain an anticodon region. It has
been proposed that the C-terminal region of SmpB forms a helix that interacts
with the decoding center to activate GTP hydrolysis by EF-Tu. The sites of
interaction between SmpB and the ribosome have recently been mapped; the Cterminal region of SmpB interacts with the ribosome in the mRNA channel in the
30S region of the A and P sites (56). This finding suggests that SmpB may
activate GTP hydrolysis through the same mechanism as a canonical codonanticodon interaction, transmitting a signal from the region of 1492 and 1493 in
the 30S subunit to the GTPase associated center in the 50S subunit.
After tmRNA•SmpB is bound to the ribosome and GTP is hydrolyzed by
EF-Tu, the nascent peptide is transferred from the P-site tRNA to alanyl-tmRNA.
After the P-site tRNA is deacylated, EF-G binds to the ribosome and promotes
translocation of the peptidyl-tmRNA to the P site. Movement of tmRNA•SmpB
into the P site causes the problematic mRNA to be rapidly released from the
ribosome, promoting its degradation (60, 61).
During the translocation of tmRNA from the A site to the P site, the
ribosome switches templates and begins translating tmRNA. The most notable
part of this template-swapping event is that the ribosome resumes translation in
the correct frame without any Shine-Dalgarno sequence or start codon (AUG).
How the ribosome recognizes the correct resume codon is an area of active
investigation. It has been shown that the nucleotide sequence just upstream of
the resume codon is important for this process (62).
Translation of the ORF of tmRNA in E. coli results in the addition of an 11
amino acid tag to the C-terminus of the nascent peptide; this includes the Ala
from tmRNA and the ten amino acids encoded in the ORF. In E. coli this region,
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positioned between pk1 and pk2, encodes the sequence ANDENYALAA. This
sequence is specifically recognized by ClpXP, Lon, and other cellular proteases
that degrade any peptide bearing it (63); addition of this tag ensures that the
malformed protein will be rapidly destroyed. Although the wild-type ORF is
essential for tmRNA to carry out its biological role, the sequence can be modified
without destroying tmRNA activity (50, 64); a number of different species encode
variations of length and peptide sequence in the ORF of tmRNA found in E. coli
(65).
The tmRNA ORF ends with a stop codon. When the ribosome reaches this
stop codon, canonical termination and ribosome recycling occur. This effectively
marks the completion of ribosome rescue by trans-translation. In fulfilling the
essential task of releasing stalled ribosomes, trans-translation also leads to the
destruction of the defective mRNA and aborted polypeptide.

Regulatory Ribosome Stalling
Many of the known causes of ribosome stalling are the result of problems
with translation such as premature transcriptional termination and broken or
decayed mRNA (from the 3′ end), but not all ribosome-stalling events are
harmful to the cell. As illustrated earlier, ribosome stalling may be used to
regulate gene expression; in such cases trans-translation would destroy the
regulatory mechanism. As was mentioned, tmRNA does not rescue stalled
ribosomes with occupied A sites. It appears that blocking tmRNA access to the
A site is a common means of protecting regulatory peptides and regulated
mRNAs from destruction by tmRNA. Ribosomes stalled during elongation that
still contain an mRNA transcript cannot be rescued by tmRNA until the mRNA
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is cleaved. In chapter three we will address questions related to trans-translation
and regulatory ribosome stalling.

CONCLUSION
Although the mechanisms of many steps of translation have been resolved
at the molecular level, numerous questions still remain unanswered. The
research presented in chapter two focuses on determining how the ribosome
resumes translation in the correct position on the ORF of tmRNA. It was
hypothesized that pk1 plays a role in positioning the resume codon and is thus
essential for tmRNA function. Our work challenges this hypothesis; it shows
that tmRNA can function at nearly wild-type levels even when pk1 is replaced
with an unrelated structure.
In chapter three we move our focus from ribosome rescue to ribosome
stalling. This research was driven by two questions: What peptide sequences can
cause ribosome stalling and how do they do this? Using a genetic selection to
screen a randomized peptide library, we have identified a number of novel
peptide sequences that cause ribosome stalling. Three of these peptides were
characterized to determine how they stall ribosomes. This characterization
reveals notable similarities as well as significant differences between the
mechanism of stalling on regulatory peptides and those we have identified.
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CHAPTER 2: GENETIC ANALYSIS OF THE STRUCTURE
AND FUNCTION OF TMRNA PSEUDOKNOT 1
Adapted from: Tanner, D.R., Dewey, J.D., Miller, M.R. & Buskirk, A.R. Genetic

analysis of the structure and function of transfer messenger RNA pseudoknot 1. J
Biol Chem 281, 10561-6 (2006).
ABSTRACT
tmRNA rescues stalled ribosomes in eubacteria by forcing the ribosome to
abandon its mRNA template and resume translation with tmRNA itself as a
template. Pseudoknot 1 (pk1), immediately upstream of this coding region in
tmRNA, is a structural element that is considered essential for tmRNA function
based on the analysis of pk1 mutants in vitro. pk1 binds near the ribosomal
decoding site and may make base-specific contacts with tmRNA ligands. To
study pk1 structure and function in vivo, we have developed a genetic selection
that ties the life of E. coli cells to tmRNA activity. Mutation of pk1 at 20% per
base and selection for tmRNA activity yielded sequences that retain the same
pseudoknot fold. In contrast, selection of active mutants from 106 completely
random sequences identified hairpin structures that functionally replace pk1.
Rational design of a hairpin with increased stability using an unrelated sequence
yielded a tmRNA mutant with nearly wild-type activity. We conclude that pk1’s
role in tmRNA function is purely structural and that it can be replaced with a
variety of hairpin structures. Our results demonstrate that in the study of
functional RNAs, the inactivity of a mutant designed to destroy a given structure
should not be interpreted as proof that the structure is necessary for RNA
function. Such mutations may only destabilize a global fold that could be
formed equally well by an entirely different, stable structure.
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INTRODUCTION
tmRNA plays an important role in quality control of protein synthesis in
eubacteria (66, 67). This dual-function RNA acts as both tRNA and mRNA to
rescue ribosomes stalled on broken templates or at certain nascent peptide
sequences (35). Aminoacylated tmRNA enters the A-site of stalled ribosomes
and transfers alanine to the growing peptide chain as would a normal tRNA.
The ribosome then resumes
translation with tmRNA as the
template, adding a ten amino acid
tag to the nascent polypeptide. As a
result of tmRNA action, stalled
ribosomes are released and recycled
and the aborted protein product is
marked for destruction by proteases
(66, 67).
In the trans-translation model
of tmRNA function described above,
the ribosome switches templates
while synthesizing a single
Figure 2-1. Secondary structure of E. coli
tmRNA.
Four pseudoknots (pk1-4) dominate the global
tmRNA structure. The tag template lies
between pk1 and pk2, with the resume and stop
codons marked with white boxes. TLD = tRNAlike domain. Adapted from (68).

polypeptide. How does tmRNA
position itself inside the ribosome for
translation to resume in the correct
frame? The global fold of tmRNA

places the first codon near the decoding center of the ribosome; a short singlestranded sequence immediately upstream of this initial codon determines the
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precise frame (69-71). The global structure of tmRNA is dominated by several
pseudoknot structures surrounding the tag-encoding sequence (45, 72). The E.
coli tmRNA, for example, has four pseudoknots (Figure 2-1).
Only 11 nucleotides upstream of the resume codon, pseudoknot 1 (pk1)
may be involved with positioning the template in the ribosomal A site. The cryoEM structure of the 70S ribosome bound to tmRNA and its partner protein SmpB
reveals that while pk2-4 are looped around the beak of the 30S subunit without
forming extensive contacts with the ribosome, pk1 is bound intimately between
the beak and the decoding center on the 30S subunit (57). Valle et al. speculate
that pk1 is pulled toward the decoding center as tmRNA transitions from the
initial binding complex visualized by cryo-EM to full accommodation in the Asite, resulting in Ala transfer and tmRNA translocation to the ribosomal P-site
(57).
In vitro studies support the conclusion that pk1 plays a crucial role in
tmRNA function. Although pk2-4 are dispensable for trans-translation in vitro,
replacing pk1 with single-stranded sequence destroys tmRNA function (47).
Mutations designed to disrupt the base-pairing of pseudoknot 1 helices reduce
tmRNA-mediated tagging dramatically (48). Alteration of single-stranded loop
sequences lowers activity, leading to proposals that these nucleotides form Mg2+
binding sites (48) or make base-specific contacts with the ribosome (73).
One limitation in the study of the trans-translation system has been the
lack of a robust in vivo selection for tagging activity. The ssrA gene that encodes
tmRNA in E. coli is not essential for growth under laboratory conditions (67).
One report of a genetic selection takes advantage of tmRNA-mediated tagging
and proteolysis of the Arc repressor, allowing derepression of the kanR gene and
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survival on kanamycin (69). The authors characterized 2451 colonies by replica
plating and reported high background (~0.1%); this screen is not robust enough
to search through large collections of mutants (libraries) of tmRNA or other
components of the tagging machinery.
To extend the study of tmRNA structure and function to a relevant in vivo
context, we have created a genetic selection that ties tmRNA function to the life
of an E. coli cell. This selection allows the characterization of millions of mutants
of tmRNA in a single experiment. Here we describe the application of this
selection to identifying the structural and functional requirements for
pseudoknot 1. How does the pk1 sequence determine its structure and what role
does pk1 play in positioning tmRNA correctly inside the ribosome for
resumption of translation on tmRNA?

RESULTS
Development of a Selection for tmRNA Activity
The function of tmRNA in vivo is to tag mistranslated proteins with an
eleven amino acid sequence. If this tag could be altered to confer protein
function rather than proteolysis, the activity of the tagged protein would reflect
the level of tmRNA function. To provide a genetic selection, the protein must be
required for cell survival and have essential residues in its C-terminal ten to
twenty amino acids. In the absence of tmRNA activity, the truncated protein
would be inactive and the cells would die; in the presence of an active tmRNA
variant, the protein could be tagged with the essential amino acids to form a
functional enzyme and confer cell survival (Figure 2-2).
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Figure 2-2. Genetic selection for tmRNA activity.
Ribosomes stall on a truncated kanR template (kanRΔ15) at the Glu-Pro-(Opal) sequence. Active
tmRNA molecules with a mutant template sequence add the final 15 amino acids of KanR (shown
in red) to the nascent polypeptide (yellow). These C-terminal 15 residues form a structurally
critical helix in the crystal structure of the homologous Aph(3’)-IIIa protein (74). tmRNA function
is linked to KanR activity and cellular survival, yielding 106-fold enrichment of active sequences.

The selection protein we chose is the E. coli kanamycin resistance protein
(KanR). Analysis of the homologous Aph(3’)-IIIa : kanamycin co-crystal
structure (Figure 2-2) reveals that the C-terminal helix of 15 residues (shown in
red) plays an important role both structurally and catalytically in binding the
substrate (74). Deletion of these residues leads to loss of function: cells
expressing the KanR C-terminal deletion (kanRΔ15) show no more kanamycin
resistance than cells lacking the kanR gene.
Natural tmRNA sequences encoding the peptide tag vary in length and
composition and can be altered without loss of function (64, 75). We replaced the
natural tag template with a sequence encoding ANKLQFHLMLDEFF and
expressed tmRNA from its own promoter from the tmRNA-K1 plasmid.
Following transfer of Ala from the tmRNA itself, the addition of these 14
residues encoded by tmRNA restores the missing 15 amino acids that make up
the C-terminal helix of KanR. We found that the identity of the resume codon
was an important factor: GCA was significantly more active than AUG, the
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wild-type kanR codon (data not shown). All known tmRNA template sequences
contain GNN resume codons (75). Presumably G at this position is important for
the recognition of the proper frame for reinitiation of translation by the ribosome.
In order for the altered tag to complete the KanR protein correctly,
ribosomes must stall at exactly the right position on the kanRΔ15 mRNA.
Ribosomes stall during termination at inefficient stop codons such as the opal
codon (UGA) when the protein sequence terminates in proline (35). The E. coli
YbeL protein, for example, ends in Glu-Pro-(Opal) and is tagged with good
efficiency (up to 40%) by tmRNA precisely at the position of the stop codon (35).
Two mutations in kanRΔ15, Asn255Glu and Met257Opal, create a Glu-Pro-(Opal)
sequence in the kanR mRNA that acts as a signal to induce ribosome stalling,
yielding the kanR-SEP selection gene. Based on the structure of Aph(3’)-IIIa, the
KanR protein is expected to have a surface-exposed loop of five residues, ending
in Pro256, preceding the C-terminal helix (74). This loop permits the
introduction of the Glu-Pro-Ala scar introduced by these changes and transfer of
Ala from aminoacylated tmRNA without affecting KanR function.
Tagging of the truncated KanR polypeptides on stalled ribosomes by the
altered tmRNA generates full-length, functional KanR protein, conferring
kanamycin resistance to cells. We co-transformed an E. coli strain lacking
tmRNA with the kanR-SEP and tmRNA-K1 plasmids. When plated onto media
containing 15 µg/mL kanamycin, all of the co-transformants survive at 37 °C.
Under the same conditions, only 5 out of 107 bacteria with kanR-SEP but lacking
the modified tmRNA-K1 survive. The enrichment ratio is roughly a factor of 103
better than the previous genetic selection for tmRNA function (69).
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Conservative Mutagenesis of pk1
This genetic selection for trans-translation provides a method to rapidly
identify active tmRNA sequences from libraries of millions of mutants.
Conserved bases in the sequences of active mutants reveal which positions
contain information required for function. This strategy of mutagenesis and
selection was used to characterize the relationship of the pk1 sequence to its
structure and function.
In creating a library of pk1 mutants, we biased the sequences towards the
wild-type pk1 sequence in order to retain the overall pk1 fold thought to be
required for tmRNA function. We randomized the sequence of pk1 at the rate of
20% per base (see Materials and Methods). Analysis of mutants prior to selection
revealed that an average of 7 mutations were introduced at random positions in
the 30 nucleotides of pk1. The library of ~ 4 x 107 tmRNA mutants was
introduced with the selection gene into an E. coli strain lacking tmRNA.
Following selection at 25 °C on 15 µg/mL kanamycin, 104-105 colonies survived.
The comparison of 67 pk1 sequences from the selected tmRNAs gives a
clear picture of what positions are tolerant to mutation. The average number of
mutations per pk1 sequence was 1.4, significantly lower than the average of 7 in
pre-selection sequences. This was expected given the sensitivity of the pk1
structure to mutation. The results in Figure 2-3 indicate the information required
at each position by the total height (e.g. position 61 has low information content
and is very tolerant of mutations). Since the greatest possible mutagenesis at
each position is 20%, the sequence is heavily biased towards the wild-type
sequence. The information content is therefore artificially inflated and the
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Figure 2-3. Consensus sequence of active pseudoknot 1 mutants.
The height at each position indicates the informational content required for function. The wildtype sequence was mutated at 20% mutagenesis per base, so differences in height and frequency
are more significant than they appear, as the sequence is heavily biased towards wild-type. Stem
1 is colored orange and stem 2 blue. Created by Weblogo (76).

differences are more significant than they appear.
The two helical regions, stem 1 (nucleotides 49-53 and 63-67) and stem 2
(nucleotides 55-59 and 74-78), are not equally important in the pk1 structure
(Figure 2-3). Stem 1 is absolutely invariant, with all the selected clones
maintaining all five possible base pairs. The wobble pair introduced by the
mutation A51G is active; likewise, mutations at the other positions are always
accompanied by covarying mutations that re-establish the base pair (e.g. G50C
and C66G). In contrast, only three of the five base pairs of stem 2 are conserved;
uncompensated mutations of the outer G55-C78 and U59-G74 base pairs are
tolerated.
Contrary to conclusions based on in vitro work (48, 73), loop 2 (nucleotides
60-62) can be mutated in vivo without affecting trans-translation. The earlier
finding that loop 2 mutants form pseudoknots but display inhibited activity led
to speculation that these bases form an Mg2+ or ribosome binding site. The strict
requirement for G or U at position 61 and G at 62 in vitro was not observed in our
in vivo assay: G61C and G62U mutants were viable.
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There is disagreement in the literature whether or not the first nucleotide
in loop 2, U60, pairs with A73 to extend stem 2 by one base pair (45, 48, 72).
Chemical probing showed that U60 is accessible but A73 protected from
modifications (48). Similarly, our findings suggest that U60 can be mutated to
the other bases without loss of function, but A73 is highly conserved. We
propose that U60 is unpaired and is part of loop 2, while A73 forms interactions
elsewhere.
The conservation of the adenosines in loop 3 (nucleotides 69-73) is
striking, particularly at the 3’-end of that sequence. Analysis of the pseudoknot
database shows that adenosine is highly enriched in loop 3 of pseudoknots
(63.9% A) particularly at the 3’-end (77). These adenosines may make A-minor
motif interactions (78) with the stem 1 helix, as seen in the high-resolution
structures of several pseudoknots (53, 79). Such interactions are consistent with
the in vitro finding that mutations in loop 3 destabilize stem 1 in tmRNA pk1
(48). Formation of A-minor motif interactions may place constraints on the
sequence of stem 1, particularly the G52-C64 and G53-C63 pairs. These positions
are invariant in all of our analyzed sequences. Construction of a covariant
mutant (G 49U51C53-G63A65C67) that alters these base-pairing patterns in stem 1 did
not restore activity in vitro (48).

Random Mutagenesis of pk1
Having learned what the requirements are for pk1 to fold correctly, we
wondered if more radical mutations could form alternate structures that function
in place of pk1. To isolate active sequences far away in sequence space from
wild-type pk1, we created a library of 1 x 106 mutants in which the entire pk1
37

Figure 2-4. Secondary structures of active pk1 replacements.
The M20 mutant was selected from a randomized sequence (N30) replacing the wild-type pk1
sequence 49-79. 20% mutagenesis of the M20 sequence and selection at higher stringency yielded
M20-2. RD2 was rationally designed using an unrelated sequence to form a hairpin structure
with increased stability. Structures and thermodynamic stabilities were predicted by the mfold
algorithm at 37 °C (81).

sequence was completely randomized (N30). This library covered but a tiny
fraction of the theoretical diversity of 430 or ~ 1018. Following selection at 25 °C
on 15 µg/mL kanamycin, roughly 50 colonies survived. Sequencing of tmRNA
sequences revealed that these mutants bear no resemblance to the wild-type pk1
sequence. None form pseudoknot structures by inspection or analysis by the
prediction software pknotsRG-mfe (80). Instead, the mutant structures are
predicted by the mfold algorithm (81) to form simple hairpin-loop structures
(e.g. mutant M20, Figure 2-4). All mfold free energy calculations and structural
predictions were performed at 37 °C.
The activity of mutants like M20 that replace pk1 with a hairpin shows
that pk1 is not required for tmRNA activity. M20 is significantly less active than
wild-type tmRNA, however, failing to confer resistance to high kanamycin
concentrations (50 µg/mL) or at higher temperatures (37 °C)—conditions under
which cells containing wild-type tmRNA display 100% survival. In a second
generation library, we mutated the M20 sequence at 20% per base over the 30
nucleotides replacing the pk1 sequence. A library of 2 x 106 M20 derivatives was
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subjected to selection on plates containing 50 µg/mL kanamycin (kan50) at 25 °C.
Of the 8 surviving clones, M20-2 is the most active, with 100% survival on kan50
at 25 °C and 50% survival on kan15 at 37 °C. The predicted secondary structure
of M20-2 contains two more base pairs than its M20 parent and is predicted to be
slightly more stable thermodynamically (−12.4 kJ/mol vs. −11.5 kJ/mol
respectively).

Quantification of pk1 Mutant Activity
Our initial analyses of M20 and M20-2 function were performed with the
KanR assay and in the tmRNA context (a mutated tag sequence) in which the
mutants were evolved. In order to correlate our assay with others in the
literature and to obtain more quantitative measures of the mutants’ activity, we
introduced the evolved pk1 sequences into otherwise wild-type tmRNA
(containing the natural template encoding ANDENYALAA). tmRNA activity
was measured by the efficiency of plaque formation by the hybrid bacteriophage

λimmP22 c2-dis. This phage only forms plaques on bacteria with intact transtranslation systems (67, 82): cells expressing wild-type tmRNA from a low copy
plasmid (pKW11) support the growth of ~1 x 105 more plaques than cells
expressing no tmRNA.
In addition to the wild-type and ΔssrA controls, we assayed two pk1
mutants that were characterized previously in vitro. The first, pk1L, replaces pk1
with a single-stranded sequence CGAGGGCCGC. This mutant is from the study
reporting that although pk2, pk3, and pk4 were dispensable for tmRNA function
in vitro, pk1 was essential (47). The second, 50CUC, maintains the pk1 sequence
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but is designed to destroy the folding of stem 1 by preventing the core three
bases from pairing. The 50CUC mutant displays a ten-fold reduction in activity
in vitro (48). Efficiency of plating (EOP) assays reveal that these two mutants are
indistinguishable from the tmRNA knockout, ΔssrA (Figure 2-5). As measured
by this assay, a missing or misfolded pk1 region renders tmRNA completely
inactive in vivo.
The M20 clone evolved from random sequence is ~ 1000-fold more active
than the missing or misfolded pk1 controls, suggesting that its hairpin structure
is sufficient to restore tmRNA stability and function (Figure 2-5). M20 is,
however, ~ 100-fold weaker than wild-type tmRNA. The M20-2 second-round
clone shows an activity 4-fold higher than M20. The cutoff for survival in the
high-stringency KanR assay must therefore lie between M20 and M20-2 activity.
The fact that the improved M20-2 mutant has more predicted base pairs
and thermodynamic stability
led to the hypothesis that
further improvements in
stability of the hairpin could
improve activity. If a hairpin
structure is all that is required
to replace the wild-type pk1,
perhaps there is nothing special
about the hairpins that we
evolved, and any stable hairpin
structure could functionally

Figure 2-5. Analysis of mutant tmRNA activity.
The hybrid bacteriophage λimmP22 c2-dis only forms
plaques on cells expressing active tmRNA (82). Data
are expressed as efficiency of plating (EOP) with wildtype tmRNA taken as EOP = 1. The del(ssrA) mutant
lacks tmRNA; mutants pk1L (47) and 50CUC (48)
destroy pseudoknot 1 folding and tmRNA function in
vitro. Error bars represent the standard deviation of
four independent experiments.
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replace pk1. To test these hypotheses, we rationally designed an eight-base pair
stem with a tetraloop, utilizing a sequence substantially different from the
evolved M20 and M20-2 clones. This rationally designed hairpin, RD2, is
predicted to be significantly more stable (−19.8 kJ/mol vs. −11.5 kJ/mol) than
the M20 hairpin (81). EOP assays show that RD2 is nearly as active as wild-type
tmRNA, 29-fold more active than M20 (Figure 2-5). These findings suggest that
the stability of the structure replacing pseudoknot 1 plays an key role in the
overall function of tmRNA mutants, but that the specific sequence used is not as
important.

DISCUSSION
Previous in vitro studies suggest that tmRNA pseudoknot 1 (pk1) is
essential to the tagging function in trans-translation. It must form a pseudoknot
structure (47, 48), may make specific contacts to the ribosome (73), and may play
a role in positioning the template region of tmRNA near the decoding center for
proper continuation of translation (57), although the precise choice of frame is
determined by the single-stranded sequence between the resume codon and pk1
(69-71).
To study the requirements for pk1 structure and its relation to tmRNA
function in vivo, we developed a genetic selection that ties the life of an E. coli cell
to tmRNA activity. KanR polypeptides lacking an essential C-terminal sequence
are stalled on ribosomes; if rescued by an altered tmRNA that codes for the
missing amino acids, the ribosomes produce full-length, functional KanR and the
cell survives on kanamycin plates. Cells lacking tmRNA activity are killed. This
selection provides the means to identify rare active mutants among large
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libraries of tmRNA, giving 106-fold enrichment of active sequences. Work is also
underway to use this genetic selection to characterize other components of the
trans-translation process.
The generation of two libraries with different levels of mutagenesis yields
apparently contradictory conclusions. The first library, generated by a
conservative mutagenesis scheme (20% per base), supports the previous in vitro
findings that mutations which destabilize the pseudoknot structure of pk1
destroy tmRNA activity. Very few mutations were tolerated: the stem 1 region
allowed covarying mutations only, maintaining all five of its base pairs, whereas
stem 2 allowed the loss of its outer two base pairs. The U60G61G62 bases of loop 2
are tolerant to mutation, suggesting that they do not form critical Mg2+ binding
sites or bind external ligands such as ribosomal components as previously
proposed (48, 73). U60 does not pair with A73; instead, A73 and other conserved
adenine bases at the 3’-end of loop 3 probably form A-minor motif interactions
with the end of stem 1. These findings about the sequence requirements of pk1
structure add a new layer of detail to what was previously known, but are
largely consistent with previous in vitro findings. They reinforce the idea that a
well-folded pseudoknot 1 structure is essential to tmRNA function.
In contrast, results from the second library, in which pk1 was replaced by
completely random sequence (N30), support the conclusion that any stable
secondary structure is sufficient. Rare mutants were isolated that substitute
hairpin-loop structures in place of pk1. A second round of mutagenesis and
selection improved the activity of the best of these clones, M20, by increasing
hairpin stability (mutant M20-2). Rational design of an even more stable hairpin,
using an unrelated sequence, created a mutant (RD2) which is nearly as active as
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wild-type tmRNA. The sequence of the hairpin appears to be much less
important than its thermodynamic stability. These surprising results were
confirmed with a standard efficiency of plating (EOP) assay using phage

λimmP22 c2-dis. This assay demonstrates that our results are not due to an
artifact of the KanR assay or the altered tmRNA tag sequence used in the
selection.
What is the resolution of these apparently paradoxical conclusions? Low
levels of mutagenesis of the wild-type pk1 sequence either destroys or retains the
pk1 fold, but total randomization allows alternate stable structures far away in
sequence space to be identified. We propose that the only requirement for the
pk1 region of tmRNA is that it forms a stable structure that prohibits other
deleterious global misfolding events. Alternate stable conformations were
detected by NMR and denaturation profiles previously in vitro (48, 73); the role
of stable pseudoknots is probably to prevent these structures from folding. A
pseudoknot structure is not necessary, however.
This finding has important consequences for mutational analyses of
structures in functional RNAs. The inactivity of a mutant designed to destroy a
given structure does not logically require that the structure is necessary for
function, as is too often assumed. The mutation may cause global folding
problems that in turn render the molecule inactive. This does not prove that the
given structure could not be replaced by a stable structure quite different from
itself. In our case, the inactivity of a mutant pseudoknot does not prove that the
structure has to be a pseudoknot; it only demonstrates that the region in question
must form a stable fold. Stability and global folding should therefore be an
important consideration in designing mutations to test hypotheses about the role
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of specific structures in RNA and in interpreting such studies. Our findings also
highlight the importance of analyzing a large number of mutants and the power
of genetic approaches to do so in an efficient manner.
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MATERIALS AND METHODS
DNA oligonucleotides were synthesized on an ABI Expedite 8909 or
purchased from Sigma-Genosys. Enzymes were purchased from New England
Biolabs.

Plasmid Construction
The tmRNA-K1 plasmid expresses the altered tmRNA gene from its own
(ssrA) promoter on a low-copy (p15A) origin with a tetracycline resistance
marker. It was created by altering the tag sequence (ANDENYALAA) to code
for the last 14 amino acids of KanR (ANKLQFHLMLDEFF). Nucleotides 90-137
of tmRNA, from the resume codon to the end of helix 5, were replaced with the
sequence GCAAATAAACTGCAGTTTCATTTGATGCTCGATGAGTTCTTCT
AATAACAGAATCTCATC. This sequence creates a stem-loop structure similar
to helix 5 following the tag template. It contains a PstI cleavage site for cloning
mutant pk1 regions immediately upstream. The tmRNA-K1 plasmid was created
by PCR amplification of pKW11 (64) using the primers
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GAGCATCAAATGAAACTGCAGTTTATTTGCGACTATTTTTTGCGGCTT
TTTAC and GATGAGTTCTTCTAATAACAGAATCTCATCCCTCTC
TCCCTAGC CTCC, followed by PNK phosphorylation and blunt end ligation.
Truncated kanR constructs were expressed from the araBAD promoter on
a multicopy (pBR322 origin) vector with a β-lactamase marker. The first version
of the selection, used in the 20% mutagenesis of wild-type pk1, induced stalling
with the sequence Pro255-Pro256-Opal. The kanR-DPP plasmid was cloned by
the amplification of the kanR gene with primers
CATATGGCTAGCATGAGCCATATTCAACGG GAAAC and
CGGCTTTTTCAAAAATATGGTATTGATCCGCCTTGAGAATTC GAGCTC,
digestion with NheI and EcoRI, and ligation into the pBAD-GFP vector.
To combine the two plasmids into a single selection vector, the tmRNA
expression cassette was PCR amplified from tmRNA-K1 with primers
CCGCTACGGTCCGAGAACTGTGAATGCGCAAACC and
TAGCGAAGATCTT AAATCCTGGTGTCCCTGTTG. The kanR-DPP plasmid
was PCR amplified with primers CGACCGAGATCTTCGCTACGTGAC
TGGGTCATG and AGTTCTCGGAC CGTAGCGGAGTGTATACTGGCTTAAC.
These fragments were digested with BglII and RsrII and ligated together.
Quickchange mutagenesis and removal of SphI and PstI sites from the resulting
plasmid, pBad-KT2, allow these unique sites surrounding the pseudoknot 1
sequence to be used for cloning. The sequence GAATAGAGGCCTTC
AACTCCGCGGATACTA was then inserted between SphI and PstI, replacing
wild-type pk1 and making tmRNA inactive. This “dummy insert” also provides
StuI and SacII sites to assist in library creation.
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A second, more active version of the selection vector was generated by
replacing the C-terminal amino acids Asp254-Pro255-Pro256 (kanR-DPP) with
Ser254-Glu255-Pro256 in the truncated kanR gene. This kanR-SEP sequence was
discovered by cloning 6 random codons after Ile253 of the truncated kanRΔ15
gene in pBad-KT2 and selecting for kanamycin resistance under more stringent
conditions: 37 °C and 15 µg/mL kanamycin. Addition of a chloramphenicol
resistance cassette into the BglII site provided a second antibiotic marker to
reduce contamination, yielding the plasmid p16Dum-Cat.
tmRNA expression vectors for the bacteriophage assays were created by
PCR amplification of the pKW11 plasmid and blunt-end cloning. The procedure
was similar to that described above to make tmRNA-K1, except that no change
was made to the tag template: the only difference from wild-type tmRNA is the
pseudoknot 1 sequence. The ΔssrA control was made by removing the entire
tmRNA sequence by digestion of pKW11 with NcoI and EcoRI, followed by
treatment with the Klenow fragment of DNA polymerase I to create blunt ends
for religation. The pk1 sequences are as follows:
50CUC, CCTCGGGCGGTTGGCCTCGTAAAAAGCCGC;
pk1L, CGAGGGCCGC;
M20, AAAAGCGTCCCGTTAGGGACGGTGGGAATA;
M20-2, AAAAGCATCCCGTTAGGGATGTTGGGATA;
RD2, AAACAGCCCGGGGAACCGGGCTGAATAAA.
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Selection of Mutant pk1 Libraries
The conservative mutagenesis of pk1 was accomplished by mutating the
30 nt of pk1 at 20% per base. The oligonucleotide
CAAGGTGCATGCCGAGGGGCGGTTGGCCTCGTAAAAAGCCGCAAAAAAT
AGTCGCAAATAAACTGCAGTTTCAT was synthesized with mixed
phosphoramidites incorporated into the positions underlined. These mixes
included 80% of the wild-type base and ~7% each of the other three bases. A
short primer bound to a constant 3’ region was extended by the Klenow
fragment of DNA polymerase I to generate double-stranded DNA. This DNA
was cleaved by SphI and PstI, ligated into the pBad-KT2 vector, and the plasmid
library introduced into DH10B by electroporation. Following plasmid
purification, the resulting library was introduced into the selection strain, X90
ssrA::cat (83). The cells were induced with 2% arabinose for 3 h at 30 °C, plated
onto media containing ampicillin, 2% arabinose, and 15 µg/mL kanamycin, and
grown for 48 h at 25 °C.
The second library, with fully-randomized pk1 sequences, was generated
in a similar manner except it incorporated N30 (25% each base) in place of the
underlined sequence above. This library was cloned into the second-generation
selection vector p16Dum-Cat and selected as above. The third library, with 20%
mutagenesis of M20, replaced the underlined sequence with mixed
phosphoramidites as above but based on the M20 sequence. The mutant inserts
were cloned into p16Dum-Cat and selected on media containing ampicillin, 2%
arabinose, and 50 µg/mL kanamycin at 25 °C. Surviving clones from these
libraries were recloned, transformed into fresh cells, grown up from single
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colonies, and reassayed under selection conditions to ensure that the tmRNA
mutant in question is responsible for the tagging activity.

Phage Efficiency of Plating (EOP) Assays
X90 ssrA::cat cells carrying a pKW11-derivative expressing pk1 mutants of
tmRNA were grown overnight in media with tetracycline at 37 °C. The cells
were washed in 2xYT media, diluted, and grown in 2xYT with 10 mM MgSO4 for
three hours at 37 °C to an OD600 of about 1. The cells were then washed with 10
mM MgSO4, resuspended to an OD600 of 0.5, and measured out into 200 µL
aliquots. 1 µL of phage λimmP22 c2-dis at various dilutions was added to an
aliquot, incubated at 37 °C for 15 minutes, and mixed with 3 mL of top agar
(2xYT, 10 mM MgSO4, and 0.7% agarose), and grown overnight at 37 °C. Plaques
on tmRNA mutants were smaller than those formed on wild-type tmRNAcontaining cells as reported previously (82). The number of plaques were
counted for four different trials as reported in Figure 2-5.
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CHAPTER 3: IDENTIFICATION AND CHARACTERIZATION OF NASCENT
PEPTIDE SEQUENCES THAT INDUCE RIBOSOME
STALLING DURING ELONGATION
ABSTRACT
TnaC and SecM are short peptides that are capable of inhibiting the
peptidy-transferase activity of the ribosome to stall translation. Although these
peptides each cause stalling by interacting with the same three regions of the
ribosome, they do so through unique interactions. Intrigued by the lack of
homology between the sequences and the unique mechanisms by which they
inhibit the peptidyl-transferase activity of the ribosome, we sought to identify
new peptides which could also inhibit peptidyl transfer. To identify novel
stalling peptides we created a genetic selection that would tie the life of the cell
to ribosome stalling. This selection takes advantage of a modified tmRNA
carrying out its natural function of recognizing stalled ribosomes and adding a
tag to the stalled peptides. With this selection we have screened a library of
randomized hexamers. Those sequences that caused stalling were tagged by
tmRNA and survived on a selective medium. From the survivors of the selection
we have identified three classes of stalling peptides: peptides containing a Cterminal Pro, peptides similar to SecM, and peptides with the novel stalling
sequence FxxYxIWPP. Further characterization of the latter class has revealed a
similar mechanism for stalling as used by SecM and TnaC, but with distinct
requirements. We conclude that ribosome stalling may be caused by numerous
sequences and is likely much more common than previously believed.
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INTRODUCTION
The ribosome efficiently synthesizes an enormous diversity of peptide
sequences without regard to their chemical properties. This generality is not
universal, however. Several peptides interact with the ribosome and induce
stalling during their own translation, either in the elongation or termination
steps (20, 84). Such translational pauses may affect protein folding before the
protein fully dissociates from the ribosome (85). Programmed stalling events
also regulate the expression of genes in both prokaryotes and eukaryotes (20, 84,
86).
In two well-characterized examples from E. coli, ribosome stalling on a
leader peptide increases the expression of a downstream gene on the same
mRNA. The secretion monitor peptide SecM, for example, regulates secA in
response to changes in protein export activity. If export activity is low, ribosome
stalling on the SecM peptide alters the secondary structure of the mRNA and
upregulates the translation of secA, a key component of the secretory machinery
(87, 88). When export activity is high, the SRP-Sec translocation system binds the
signal peptide in SecM and pulls it from the stalled ribosome. A second example
is the regulation of tnaA, an enzyme that breaks down tryptophan, by its
upstream leader peptide TnaC in response to cellular levels of tryptophan.
When tryptophan concentrations are high, ribosome stalling on TnaC blocks a
transcriptional terminator, increasing expression of tnaA. Lower tryptophan
levels do not support ribosome stalling and lead to attenuation of the transcript.
Stalling at these peptides is the result of three interactions: the binding of
the nascent peptide to the ribosomal exit tunnel and the peptidyl-transferase
center, and the binding of an effector in the ribosomal A site. The peptide exit
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tunnel in the large ribosomal subunit is 100 Å long and 10-20 Å wide (26).
Mostly made of RNA, it provides very few hydrophobic surfaces for elongating
proteins to bind, accounting for their ability to pass through unhindered. A
significantly constricted portion of the tunnel is formed by loops in proteins L4
and L22. SecM and TnaC interact with the tunnel near this constriction, using
critical Trp residues 10-12 amino acids upstream of the stalling site. Ribosomal
mutations that reduce stalling map to the exit tunnel, implicating A751, A2058,
and U2609 in the 23S rRNA and specific residues in the L22 protein in the
stalling mechanism (18, 29). A cryo-EM study of the SecM-stalled ribosome
revealed a network of conformational changes in 23S rRNA emanating from the
exit tunnel (30).
Nascent peptides also interact directly with the peptidyl-transferase center
(PTC) to induce stalling. In the case of SecM, the identity of the final five
residues is critical for stalling at the FxxxxWIxxxxGIRAG165 sequence. Likewise,
the C-terminal Pro residue in TnaC is essential for stalling at the sequence
WxxxDxxxxxxxP* (17). These amino acids must be acting within the PTC inhibit
its catalytic activity, either peptidyl transfer in SecM or peptidyl hydrolysis in
TnaC. In some cases, the peptide sequence in the PTC is sufficient to induce
stalling without exit tunnel interactions. A C-terminal Pro residue in the YbeL
protein inhibits termination, especially when preceded by the amino acids Asp,
Glu, or Pro.
In addition to nascent peptide interactions with the exit tunnel and the
PTC, the binding of an effector molecule in the A site is also required for stalling
at SecM and TnaC. SecM stalls during elongation with unreacted Pro-tRNA
bound in the A site (22, 89). Mutation of this Pro codon to Ala alleviates stalling.
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Likewise, TnaC stalling requires binding of free tryptophan near the PTC (17).
The action of free tryptophan can be mimicked by Trp-tRNA if the tnaC stop
codon is mutated to a Trp codon. Other aminoacyl-tRNAs (Phe, Met, Pro) do not
induce stalling (17). Binding of the amino acid Trp creates a PTC conformation
that leads to stalling on the TnaC peptide.
Although nascent peptide sequences that induce ribosome stalling interact
with the exit tunnel and PTC, they share little sequence similarity. This led us to
hypothesize that there are additional, unknown peptide sequences that might
inhibit peptidyl transfer or hydrolysis. Here, we report the development of a
genetic selection to identify stalling peptides from random libraries and the
characterization of peptides that stall at high efficiency during elongation. To
our knowledge this is the first systematic identification of peptides that cause
stalling through direct binding to the ribosome.

RESULTS
A Genetic Selection for Novel Stalling Peptides
We set out to systematically identify peptide sequences like SecM and
TnaC that interfere with peptidyl-transfer or hydrolysis and induce ribosome
stalling. To identify stalling peptides from random libraries, we modified a
genetic selection that we developed previously to link ribosome stalling to the
life of the cell (50). In this selection, stalled ribosomes are recognized by transfermessenger RNA (tmRNA), a small, stable RNA found in eubacteria that is part of
a quality control system for protein synthesis. tmRNA’s natural function is to
release stalled ribosomes and tag the aborted nascent peptides for destruction
(35, 64). Acting as a transfer RNA, tmRNA enters the empty A site of the
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ribosome and adds Ala to the nascent polypeptide chain. tmRNA then serves as
a template, encoding a short peptide tag that is recognized by cellular proteases.
After this tag is translated, the ribosome is released at a stop codon within
tmRNA and the aborted protein product is degraded. For the purposes of our
selection, it is important to note that although tmRNA was first characterized as
rescuing ribosomes stalled on mRNAs lacking stop codons (83), recent studies
demonstrate that it can also act on ribosomes stalled by nascent peptides (35, 90).
To create a genetic selection for ribosome stalling based on this ribosome
rescue machinery, we altered tmRNA so that instead of tagging proteins for
proteolysis, it completes the synthesis of an essential protein, linking stalling to
the life of the cell. The kanamycin resistance protein (KanR) from Tn10 has a Cterminal helix of 15 amino acids that is structurally critical; truncation of this
helix leads to loss of activity. To complement the truncated KanR protein, we
changed the tmRNA template sequence to encode the last 14 residues of KanR
(ANKLQFHMLDEFF). Together with the Ala from aminoacylated-tmRNA,
these residues complete the KanR protein and restore KanR activity—but only if
the ribosome stalls at exactly the right site. This serves as the basis for our
selection: peptide sequences that stall the ribosome at the end of a truncated
KanR protein can be easily identified in random libraries because they recruit
tmRNA, complete KanR, and confer resistance to kanamycin (Figure 3-1).
How can stalling be induced at the end of the KanR protein without
interfering with the final structure and activity of KanR? We previously showed
that two mutations, Asn255Glu and Asp257Opal, create a Glu-Pro-(Stop)
sequence that induces stalling during translational termination. Expression of
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Figure 3-1. Genetic selection for stalling peptides.
A. When the hexamers at the end of the kanRΔ15 gene cause ribosome stalling, the KanRΔ15
protein (yellow) is tagged by tmRNA-K1. The KanR tag (red) forms a helix that restores the
function of KanR. Only those library sequences that cause stalling will be tagged and survive on
kanamycin. The active KanR structure is adapted from the crystal structure of the homologous
Aph(3’)-IIIa protein (74). B. The random hexamer (blue) was inserted after I254 of KanR. The
tagged sequence contains two alanine residues then the sequence matches from N259 to the end
of the protein. Tagging on the random hexamer could occur at any point within the randomized
region.

this truncated kanR-SEP construct and the altered tmRNA, tmRNA-K1, allow
cells to survive equally well on selective (15 µg/mL kanamycin) or non-selective
plates at 37 °C. Under the same conditions, bacteria lacking the modified
tmRNA-K1 gene survive at the rate of 5 colony forming units in 107 (50). These
results demonstrate that the introduction of the Glu-Pro-Ala “scar” from the
stalling and tagging process does not destroy KanR activity. Analysis of the
crystal structure of the homologous Aph(3’)-IIa protein suggests that the Cterminal helix in KanR is preceded by a surface-exposed loop of poorly
conserved residues (Ile253 through Pro256). We anticipated that this loop region
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might tolerate a variety of sequences that induce stalling and tagging while
maintaining robust KanR function.
Nascent peptide sequences that induce ribosome stalling were isolated
from a library of random hexamers fused to the truncated KanR protein.
Eighteen amino acids were deleted from KanR, including the C-terminal helix
and three residues in the preceding loop. Random hexamers were cloned at the
C-terminus of the truncated protein beginning with KanR residue 254. No stop
codon was specified. We generated a library of 5 x 106 KanR mutants,
corresponding to roughly 10% of the theoretical diversity of a peptide hexamer
library. We transformed the library, together with tmRNA-K1, into an E. coli
strain lacking wild-type tmRNA (ΔssrA) and selected for survival on plates
containing 15 µg/mL kanamycin at 37 °C. Roughly 1 in 104 colonies survived—a
substantial fraction—suggesting that a variety of different peptide sequences can
induce ribosome stalling.

Three Classes of Stalling Peptides
Sequencing of the surviving clones revealed three classes of peptides
(Table 3-1). The most common cause of stalling, found in over 90% of the clones,
is inefficient termination at the sequence Pro-Stop. The Pro residue is found
almost exclusively at position three of the random hexamers, corresponding to
native KanR residue Pro256. While there is no significant codon bias for any
particular Pro codon, the opal stop codon (UGA) is highly overrepresented
(23/29 clones). There is also selection for the (–2) residue just upstream of Pro:
Glu is overrepresented (16/29) in the Pro-Stop clones and Asp, Pro, and Gly are
each seen several times.
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A second class of peptides induce stalling during elongation, not
termination. These clones contain two consecutive Pro codons, most commonly
at positions three and four, with no nearby stop codon. The majority of these
clones were found by lowering the selection stringency by plating at 25 °C.
When tested individually, they showed poor survival at 37 °C, roughly 1-10%,
much weaker than the 100% survival seen with the Pro-Stop sequences above.
An exception to this rule is clone 46-36 which contains a sequence (GIRAPP) that
Table 3-1. Sequences of library clones representing different modes of stalling.
Class I: sequences containing ProStop

Clone

Y G I S E P *
TATGGTATTTCTGAACCGTGAGAAAGTGGTACC

37s-16

Y G I K D P *
TATGGTATTAAGGATCCTTAGGACTAGGGTACC

37s-7

Y G I W P P *
TATGGTATTTGGCCACCTTGACTAACCGGTACC

46-1

Comments

This group consisted of greater than
90% of all the sequences identified in
the selection.

Class II: sequences with ProPro
Y G I R A P P H C G T
TATGGTATTAGGGCGCCTCCCCATTGCGGTACC

46-36

Y G I A D P P C A G T
TATGGTATTGCTGACCCACCTTGTGCAGGTACC

618-6

Y G I R S P P N S G T
TATGGTATTAGATCTCCACCGAATAGTGGTACC

618-19

Y G I L D P P G M G T
TATGGTATTCTGGATCCTCCAGGCATGGGTACC

618-20

In those clones containing Pro-Pro
without Trp, the prolines were in
postions three and four of the
random hexamer.

Class III: sequences with TrpProPro
Y G I W P P W Y R G T
TATGGTATTTGGCCCCCCTGGTATAGGGGTACC

250-36

Y G I W P P D V *
TATGGTATTTGGCCTCCGGATGTATGAGGTACC

37s-20

Y G I W P P P S I G T
TATGGTATTTGGCCACCGCCATCGATTGGTACC

46-20
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These sequences all stalled with high
efficiency. In each of the Trp-ProPro peptides, the prolines were in
positions two and three of the
random hexamer.

closely resembles the stall site of the SecM peptide (GIRAGP).
A third class of clones contain the sequence Trp-Pro-Pro without a stop
codon immediately following. Like the other Pro-Pro sequences, these peptides
must also stall during elongation rather than termination. Unlike the second
class of clones, however, the two consecutive Pro codons appear at positions two
and three rather than three and four. Clone 46-5, for example, contains the
hexamer WPPWYR. Another difference is that WPP-containing clones survive
robustly (100%) in the KanR selection at 37 °C when characterized individually.
Further experiments on these peptides are described below.
The sequence Pro-Stop occurs commonly and stalls at high levels; to
prevent such clones from overwhelming other novel sequences, we created a
second library of random hexamers in which stop codons were prevented from
occurring at positions four through six. This was done by allowing only C, G,
and A at the first nucleotide of these codons, also eliminating Phe, Tyr, Cys and
Trp at positions four through six. We screened an 8 x 106 member library at high
stringency, obtaining colonies at a 0.01% survival rate. 21/23 sequenced clones
contained the sequence WPPP at the first four positions. This result confirms
that WPP-containing sequences are robust inducers of stalling, particularly when
coupled with a third Pro codon.
Selection of this second library at low stringency yielded much higher
levels of survival (0.25%). Nearly all of these clones fall into the second class of
stalling peptides, with two consecutive Pro codons at hexamer positions three
and four. An alignment of 46 of these sequences reveals that Arg or His are
strongly preferred at the first position, with Ala, Asp, Ser, and Pro at the second
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position. Including the constant Gly-Ile upstream, the consensus sequence
becomes GI(R/H)xPPxx.

Stalling and Tagging Occur Following WPP
The peptide sequences in class three (containing WPP) show high levels of
activity in the KanR assay and stall translation during the elongation step. We
chose to further characterize three sequences: WPPPSI, WPPDV*, and WPPWYR.
Where does stalling occur in these sequences? Where is the tag added by
tmRNA? To determine the point of tagging using mass spectrometry, we first
transferred the stalling sequence to the C-terminus of the GST protein. This fulllength, stable protein served as a scaffold enabling overexpression. Some of the
KanR protein context was fused to GST as well, from 12 amino acids upstream of
the random hexamer through the first stop codon downstream:
SLQKRLFQKYGIWPPPSIGYRGSRVDRQAWLFWRMREDFQPDTD*. To isolate
proteins tagged by tmRNA, we used a modified tmRNA encoding six His
residues in its template sequence (tmRNA-H). GST-fusions tagged by tmRNA-H
were purified by affinity chromatography using Ni-NTA resin and digested with
trypsin. From this tryptic digest, the C-terminal tagged peptide was purified
again with Ni-NTA resin.
The C-terminal peptide contains both the stall sequence from KanR and
the tmRNA tag; determining its mass and peptide sequence by MALDI-MS
revealed the site of stalling and tagging by tmRNA. A single large peak in the
mass spectra for the WPPPSI and WPPWYR C-terminal tagged peptides
corresponded to a mass of 2041 Da. This is the mass expected if the tmRNA tag
is added after the second Pro (YGIWPPAANDH6D, Figure 3-2). The mass
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2041 Da

WPPPSI

2041 Da

WPPWYR

WPPDV*
2255 Da

2041 Da

Figure 3-2. Mass spectra of stalled class three peptides.
Stalled peptides are tagged with tmRNA-H, digested with trypsin and purified. The mass of
each fragment indicates the point of stalling and tagging. Stalling occurs on WPPPSI and
WPPWYR after the second Pro, as indicated by a mass of 2041 Da. WPPDV* stalls after the
second Pro, but actually stalls more efficiently at termination on Val.
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spectrum of the WPPDV* peptide fragment contained the same peak at 2041 Da
together with a more abundant peak at 2255 Da corresponding to the peptide
YGIWPPDVAANDH6D. In the WPPDV* clone, stalling occurs both after WPP
and during termination at the stop codon. Peptide fingerprinting by tandem
MS/MS was performed on all four of these peptides to confirm the amino acid
sequence directly.

Determination of Residues Necessary and Sufficient for Stalling and Tagging
The MS data indicate that stalling occurs immediately after WPP in these
three clones. What amino acids cause this stalling event? In the case of SecM
and TnaC, residues essential for the highest levels of stalling are found upstream
and interact with the exit tunnel. For this reason we included 12 amino acids
(SLQKRLFQYGI) from KanR along with the hexamers in making the GSTfusions. To assay for stalling and tagging in the GST-fusions, we detected the tag
added by tmRNA-H with anti-His6 antibodies. High levels of tagging were
detected for the full-length GST-WPPPSI fusion (1-18: 12 residues from KanR
followed by the hexamer) (Figure 3-3 B). Deletion of the first four amino acids
had little or no effect (5-18), but removal of the first eight nearly eliminated
tagging (9-18). We conclude that residues upstream of the WPPPSI sequence
play a critical role in high-efficiency tagging. Interestingly, some minimal
activity resides in the hexamer sequence alone (13-18) with no KanR upstream
sequence. Analysis of the GST fusions using anti-GST antibodies reveals that
stalling is indeed efficient; far higher levels of full-length GST are seen when
tagging and stalling are lost.
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Figure 3-3. Determining essential components of stall peptide.
Immunoblots of full-length (Fl) and truncated constructs of the WPPPSI library selectant.
A. The stall peptide was divided into four regions, numbering from the N-terminus of the
library sequence. B. Removing 4 amino acids at a time from the N-terminus of the stall
peptide indicated where the residues essential for stalling were located. A +1 frameshift (FS)
was also assayed for tagging. C. Individual alanine mutations were made in each position of
the Fl stall peptide WPPPSI. The amino acid replaced in each mutant is listed above its
representative lane. A coomassie stain served as a loading control for each of the different
mutants.

To identify how each residue contributes individually to stalling, we
performed alanine scanning on the full-length stalling peptide (1-18). Residues 1
to 16 were individually mutated to alanine and assayed by immunoblot.
Consistent with the truncation results, mutating residues 1-4 had little or no
effect on tagging (Figure 3-3 C). Alanine substitutions for Arg5, Leu6, Gln8 and
Lys9 likewise made little difference in the level of stalling. In contrast, the
Phe7Ala and Tyr10Ala mutants dramatically decreased tagging levels. The
requirement for Phe7 explains why truncating residues 1-8 strongly lowers
tagging above. Stalling was eliminated by mutating Ile12 or of any residue in the
WPP sequence to Ala. Notably, tagging was also eliminated by the Pro16Ala
mutation. This is surprising because the MS data shows that the third Pro in
WPPPSI is not incorporated into the stalled peptide.
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tmRNA rescues ribosomes stalled on broken or defective mRNA
templates; perhaps these tagging events arise from RNA synthesis defects in the
KanR mRNA or post-transcriptional nucleolytic cleavage. To prove that tagging
requires translation of the peptide sequence, we created a mutant of the GSTWPPPSI fusion in which a single nucleotide is added upstream of the full-length
stall peptide. The resulting +1 frameshift changes the identity of every amino
acid in the stalling sequence except for Phe7 and Lys9 while retaining the same
nucleotide sequence. Immunoblot analysis of this mutant revealed that tagging
was completely abolished, demonstrating that stalling on the GST-WPPPSI
fusion is due to the amino acid sequence and not the nucleotide sequence (Figure
3-3 B).
The role of Codon Usage
We anticipated at the outset of our KanR selection experiments that we
would isolate stalling sequences with rare codons. The three tRNAArg
isoacceptors decoding the CGG, AGA, and AGG codons are present at low levels
in E. coli (91). Overexpression of proteins containing consecutive rare codons
induces high levels of stalling and tagging by tmRNA (92). Why do such
sequences not survive the KanR selection? To address this question, we
measured tmRNA tagging levels for a GST-fusion construct containing SEPR*
and SEPRRR encoded by the rare Arg codon AGG. SEPR* stalling was barely
detectable, much lower than SEP*, while SEPRRR tagged at very high levels in
the immunoblot assay. Tagging at both sequences was completely alleviated by
overexpression of the cognate tRNAArg from a plasmid (pRARE) (Figure 3-4 A).
The same SEPR* and SEPRRR sequences were then cloned in place of the
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Figure 3-4. Immunoblot
showing effects of rare codons.
Cells were grown with or
without the pRARE plasmid,
which overexpresses a rare Arg
codon and a rare Pro codon. A.
Stalling on the sequence SEP* is
unaffected by pRARE, but it is
completely relieved on a rare
Arg sequence with
supplemented tRNAArg. B. The
rare proline codon that is
complemented by proL on
pRARE does not affect stalling
on WPPPSI except when placed
in the position of the third Pro.
This dramatically reduces the
overall expression of GST (equal
amounts of total protein were
verified by coomassie staining).

A

B

randomized cassette of the kanR selection plasmid. The sequence SEP in the first
three positions is known to be compatible with KanR activity; in the SEP* context
it conveys 100% survival. Cells expressing these plasmids survived no better
than an empty vector control under low stringency conditions (data not shown).
These results show that tagging activity at rare codons is either insufficient or
incompatible with restoring KanR function.
What is the role of codon usage in the WPP-containing sequences isolated
in the KanR selection? All four Pro codons were found in the sequences
encoding these clones. There was no obvious selection for individual codons in
the WPPP sequences isolated in the second library. Nevertheless, it is possible
that stalling or tagging at WPPPSI requires depletion of Pro-tRNAPro in the cell; if
so, then overexpression of tRNAPro should alleviate stalling or tagging. To test
this hypothesis, we altered the WPPPSI coding sequence to include one or more
CCC codons. CCC is decoded by only one tRNA, Pro2, which also recognizes
CCU (91). The original WPPPSI sequence contains neither CCC nor CCU; we
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altered it to include CCC at the first two Pro codons (WppPSI), the third
(WPPpSI) or the first and third (WpPpSI).
The immunoblot assay was used to visualize the tagging levels of these
GST-fusions with or without overexpression of Pro2 from the proL gene on the
pRARE plasmid (Figure 3-4 B). Tagging of the original WPPPSI sequence lacking
CCC codons was unaffected by overexpression of proL. Likewise, little or no
change in tagging occurred when the first two Pro residues were encoded by
CCC (WppPSI). In contrast, when the third Pro codon was CCC, tagging was
sharply reduced by proL overexpression. In addition to the loss of tagging, the
overall expression of the GST-WPPpSI and WpPpSI fusions was dramatically
reduced. proL had no effect on GST levels in WPPPSI or WppPSI. These results
show that depletion of the tRNA decoding the third Pro codon is necessary for
tagging. When that tRNA is abundant, tagging does not occur and,
paradoxically, GST expression is dramatically reduced.
Tagging at Termination in WPPDV*
The MS data show that tagging occurs in the WPPDV* sequence both
immediately after the WPP sequence and during termination at the stop codon
after WPPDV. To further understand the effect on termination, we measured
tagging levels for a series of GST-WPPDV* variants in the immunoblot assay.
Mutation of the opal (UGA) stop codon to the more efficient ochre (UAA) codon
reduced tagging slightly; replacing the stop codon altogether with an Ala codon
reduced it even further. We propose that the substantial tagging that remains in
the WPPDVA variant likely represents stalling directly after the WPP, as seen in
the MS data.
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Figure 3-5. Immunoblot analysis of mutations on WPPDV*.
Ribosomes stall on WPPDV* after the second Pro and at termination after Val. Replacing the
opal codon with the more efficient ochre codon slightly decreases stalling efficiency.
Removing the stop codon completely also diminishes the level of tagging. Stalling is
completely abolished when Asp is removed. The spacing between the stop codon and Asp
also appears to play a role in stalling efficiency.

If the WPPDV sequence is interfering with termination, how far
downstream does this effect carry? An opal stop codon immediately following
WPPD tagged at the same level as the original WPPDV* sequence. Moving the
stop codon one or two codons downstream by inserting Ala residues, however,
reduces the tagging levels to those lacking a stop codon altogether (WPPDVA).
These results show that the stop codon must be only one or two codons
downstream of WPPD for stalling to occur during termination.
We next examined the role of the Asp and Val amino acids immediately
upstream of the stop codon. Val is not known to inhibit termination when found
at the C-terminus of proteins; indeed, the Val17Ala mutant showed no loss of
tagging. The Asp16Ala mutation, however, completely alleviated tagging
(WPPAV*). The Asp residue must therefore be critical for tagging after WPP as
well as after WPPDV during termination. This role is consistent with the critical
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nature of the third Pro residue in WPPPSI even though neither is incorporated
into the tagged protein.

The Residue after WPP is Critical for Stalling
Alanine-scanning mutagenesis of both the WPPDV* and WPPPSI clones
demonstrates that the residue after WPP, either Asp or Pro, plays a key role in
stalling ribosomes. To identify which amino acids might satisfy this
requirement, we created a library of peptide trimers following WPP in the KanR
selection (WPPXXX), constrained as above to prevent stop codons. Following
selection at high stringency, sequencing the surviving clones revealed that ~80%
contained the sequence WPPPxx and another ~20% the sequence WPPDxx. No
selection was apparent for the final two amino acids. To obtain a more
quantitative picture, we created mutants of the GST-WPPPSI fusion expressing
all of the possible amino acids after WPP (i.e. WPPxSI). These were subjected to
immunoblot analysis with tmRNA-H (Figure 3-6). Confirming the genetic data,
the Pro, Asp, and Trp mutants showed high levels of tagging, while the other 17
amino acids showed much lower levels of tagging.
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Figure 3-6. Immunoblot of WPPxSI.
Immunoblots were performed on WPPxSI variants encoding each of the 20 amino acids in the
third position of the hexamer. An anti-His6 antibody was used to detect tmRNA-H tagged
peptides. Stalling is reduced to virtually nothing unless the third position is a Pro, Trp, or Asp.
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Ribosomal Interactions Necessary for Stalling
Both the KanR and the tmRNA-H immunoblot assays rely on tmRNA
function to measure levels of ribosome stalling. To detect stalling directly, we
inserted the WPPPSI 18mer after residue nine of lacZ and assayed for the activity
of β-galactosidase. Our stall peptides were compared to SecM and a non-stalling
SecM control that has an Ala substitution of the C-terminal Pro (GIRAGA). As
shown by Nakatogawa and Ito (18), the SecM peptide dramatically inhibits βgalactosidase expression which is 1300-fold higher in the non-stalling Ala
mutant. The 18-mer WPPPSI peptide also reduced lacZ expression, though not
as well as SecM (116 versus 8 Miller Units of remaining activity). Mutation of the
second Pro residue, shown above to result in loss of tagging, likewise resulted in
96-fold higher LacZ activity. These results show that our selected peptide
sequences induce stalling with high efficiency using an assay that measures
stalling directly rather than relying on tmRNA-mediated tagging.
Ribosomal RNA mutations that map to the exit tunnel have been shown to
affect stalling at SecM, and TnaC. Does WPPPSI interact with the same
ribosomal RNA nucleotides? Using β-galactosidase assays, we measured the
effect of several 23S rRNA mutations on stalling at the WPPPSI 18-mer. 23S
rRNA mutants known to affect stalling on other peptides were overexpressed in
the presence of wild-type ribosomes. Consistent with the findings of
Nakatogawa and Ito (18), the efficiency of stalling on SecM was markedly
decreased (78-fold) when translated by ribosomes with the 2058G mutation
(Figure 3-7). Likewise, efficiency of stalling on SecM was decreased, though to a
lesser extent (six-fold), in the presence of ribosomes with an A insertion at
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nucleotide 751. We also analyzed SecM-stalling in the presence of three rRNA
mutants that were studied in connection with TnaC. We found that the U2609A
mutation reduced stalling somewhat (eight-fold) while the U2609C mutation had
no effect.
While the stalling efficiency at WPPPSI is not as great as SecM, stalling
was further reduced by the both the U2609A and U2609C mutants (seven-fold).
The U754A and A751 insertion mutations, in contrast, showed no significant
effect. Another notable result is the different effect of the A2058 mutation on
stalling at SecM and WPPPSI. This mutation was the most effective at relieving
stalling on SecM but actually increases stalling on WPPPSI (eight-fold). These
results show that WPPPSI interacts with some of the same rRNA nucleotides as

WT

A2058G

A ins 751

U754A

U2609A

U2609C

WT rib
(mut peptide)

Figure 3-7. Effects of 23S RNA mutations on stalling of WPPPSI and SecM.
The efficiency of stalling on SecM (red) or WPPPSI (blue) in the presence of 23S mutants was
measured using a β-galacotsidase reporter assay. The original stalling peptides were expressed
with the noted 23S mutants. The two columns on the right are mutant stalling peptides WPAPSI
(blue) and GIRAGA (red) of SecM expressed in cells with wild-type 23S RNA. Note the different
scale for the mutant peptides.
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SecM or TnaC but that a unique pattern of exit tunnel interactions is required for
each peptide.

DISCUSSION
We performed a genetic selection to identify novel peptides that inhibit
peptidyl-transferase activity during their own synthesis. The selection is based
on the ability of tmRNA to recognize and rescue stalled ribosomes. When
stalling occurs at the C-terminus of a truncated KanR protein, tmRNA encodes
the missing amino acids to complete the protein and restore KanR activity.
By far the most common source of stalling that we identified is inefficient
termination at Pro-Stop sequences. Several components need to be present to
cause high-efficiency stalling during termination. First, the opal (UGA) stop
codon was strongly preferred over the other two stop codons in the selection.
UGA is the least efficient stop codon, leading to readthrough and recoding
events, such as the programmed frameshift at an opal codon in the RF2 gene (93).
Pro-opal sequences in particular cause strong +1 frameshifting at CCC_UGA
sequences (94) and significant levels of stalling and tagging by tmRNA. These
phenomena may derive from the lower rate of peptide releae by RF2, the factor
recruited by UGA codons. As seen in previous studies, the residue upstream of
Pro is also critical for maximal stalling efficiency (35). In particular, Glu, Asp,
and Pro were overrepresented in the –2 position (e.g. Glu-Pro-opal) in our
selectants. These results validate our selection and demonstrate that survival in
the KanR assay requires high levels of ribosome stalling.
A second set of selectants show weaker activity (surviving only at low
stringency) and contain the consensus sequence GI(R/H)xPP. It seems likely
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that these peptides are subtle variants of the SecM sequence GIRAGP166. The
GIRAPP clone that matches SecM the most closely survives even at high
stringency. The only difference with SecM is that Pro replaces Gly in the
ribosomal P site upon stalling. This suggests that some alterations in this critical
SecM sequence are tolerated. The following mutations result in substantial
though lesser KanR activity: Arg163His or replacing Ala164 with Asp, Ser, or
Pro. It is interesting to note that the GI residues were not part of the random
hexamer library; by chance, these were the two amino acids just upstream. Like
the Pro-stop sequences above, the first Pro codon in GIRAPP is in position three
in the hexamer where by analogy with SecM, stalling occurs. Such sequences are
easily found in low stringency selections because the consensus sequence
(R/H)xPPx is easily specified. There is no reason to suspect that these residues
were selected solely for KanR function based on the alignment of proteins
homologous to KanR.
Overexpression of SecM has been reported to result in high levels of
tagging by tmRNA, though such tagging is probably not biologically relevant
(43, 89). Tagging occurs even with a shortened SecM sequence, IRAGP, lacking
the Trp residue that interacts with the exit tunnel near the L4/L22 constriction. It
is likely, however, that tagging by tmRNA is an artifact of overexpression. In
order to properly regulate and respond to SecA levels, stalled SecM peptides
must be removed by the secretory machinery (95). Furthermore, tagging
requires the removal of mRNA downstream of the stalled ribosome—the very
secA cistron upregulated during SecM stalling. In these ways, the rescue of
stalled SecM peptides by tmRNA would interfere with its biological function.
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The presence of aminoacyl-tRNAGly in the A site likely blocks tmRNA
from acting on stalling peptides that regulate gene expression. TnaC and
ErmCL, a third regulatory stalling peptide, are not tagged by tmRNA because
the A site of the ribosome is occupied by either RF2 or Ser-tRNA, respectively
(16, 21). Likewise, SecM stalls with unreacted Pro-tRNA in the A site. Hayes et
al. showed that SecM overexpression depletes Pro-tRNA, creating a subset of
ribosomes stalled on SecM with empty A sites. Following a period of prolonged
stalling, the downstream mRNA is degraded and tmRNA can enter the stalled
ribosomes and tag SecM. These authors also report that overexpression of ProtRNA eliminates this tagging (89).
Like these stalling peptides, our WPP-containing selectants stall with
peptidyl-WPP-tRNA in the P site and unreacted aminoacyl-tRNA in the A site.
In the case of the WPPPSI clone, for example, the mass spectrometry data show
that stalling occurs after WPP. Yet the Ala scanning data show that the next
residue (the third Pro) is required for stalling and tagging, even though it does
not react with the nascent peptide. We conclude that it is the peptidyltransferase activity that is inhibited in WPP-containing peptides, not another step
in the translation process, such as translocation. This implicates changes in the
conformation of the PTC in the stalling mechanism. Like SecM, tagging at
WPPPSI cannot occur when the A site is occupied. Overexpression of the tRNA
decoding the third Pro codon abolishes tagging. At the same time, tRNA
overexpression actually lowers GST expression because stalling is more robust
with the tRNA in the A site, and no GST-stalled ribosomes are released by
tmRNA.
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The amino acid Pro plays two different roles in the WPPPSI clone. First,
Pro-tRNA acts as a poor peptidyl acceptor in the A site. N-alkylamino acids such
as Pro have been shown to act as slow nucleophiles in the peptidyl-transferase
reaction (96). Using full-length tRNAs, Pavlov et al. demonstrated that ProtRNAPhe reacts 23-fold slower with fMet-tRNAfMet than Phe-tRNAPhe does. They
propose that this is due to steric effects and reduced nucleophilicity of the
secondary amine. Interestingly, the rate of Pro reactivity is accelerated by the
natural tRNAPro isoacceptor; Pro-tRNAPro only has a three to six-fold defect. The
slow reactivity of Pro is used in natural stalling sequences: Pro-tRNA must bind
in the A site for stalling to occur on SecM (22). Pro-tRNA plays a similar role in
stalling on 2A peptides in viral genomes. 2A peptides stall at the Gly residue in
the sequence D(V/I)ExNPGP, terminating protein synthesis after Gly(97, 98).
We propose that the reduced rate of peptidyl-transfer to Pro in the WPPPSI
sequence gives the nascent peptide time to interact with the exit tunnel and PTC,
shifting the 23S rRNA to an inactive conformation.
While Pro-tRNA is known to react slowly in the A site, our work suggests
that other aminoacyl-tRNAs may play a similar role. WPPD and WPPW
sequences were also isolated from our peptide libraries. Replacing the Asp
residue with Ala abolished tagging at WPPDV*. Immunoblot analysis revealed
that tagging only occurs if the residue following WPP is Pro, Asp, or Trp; the
other 17 amino acids show much lower levels of tagging. This interaction is
probably specific for the amino acid, not the codon or tRNA alone. The amino
acid is the key component of Pro-tRNA in SecM; the Pro analog azetidine
dramatically reduces stalling. Likewise the binding of free tryptophan or Trp-
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tRNATrp is required for stalling at TnaC. Trp binding in the A site must be based
on ribosomal interactions with the amino acid itself.
The second role of Pro in WPPPSI stalling is that it acts as a poor peptidyl
donor. Slow reactivity of nascent peptides with Pro in the P site has also been
observed previously. In a purified translation system, peptides ending in Pro
react with puromycin slower than peptides ending in any of the other 20 amino
acids (99). C-terminal Pro residues also inhibit release factor function, as seen
above in the Pro-Stop clones, TnaC, and the UL4 gene of the mammalian virus
CMV (ending in IPP) (84). It seems likely that the cyclic Pro residue interferes
with conformational changes in the PTC that are required for both elongation
and termination.
The sequence context has a great effect—upstream peptide sequences are
required for high-efficiency stalling. Stalling in the WPPPSI clone requires the
consensus peptide sequence FxxYxIWPP. Phe7 and Tyr10 are aromatic residues
that may bind rRNA in the exit tunnel. Phe7 is nine residues away from the P
site, the same length as the ErmCL peptide. This provides sufficient length for
the peptide to interact with the L22 constriction. Closer to the PTC, the Ile four
residues away from the P site is necessary for stalling in both ErmCL and SecM
as well as WPP-containing peptides, presumably because of hydrophobic
interactions with rRNA nucleotides in the entrance of the nascent peptide exit
tunnel (16, 18). The ErmCL peptide probably binds the antibiotic as well as the
PTC; the additional sequence requirements of SecM, TnaC, and FxxYxIWPP
peptides are required to bind the exit tunnel directly.
The WPP-containing peptides that we discovered stall ribosomes robustly:
in the lacZ assay, the WPPPSI 18-mer sequence reduced activity nearly 100-fold
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over the WPAPSI mutant. This result is also important because it demonstrates
stalling without using tmRNA-mediated tagging. In tagging assays, full-length
GST is expressed at far higher levels in non-stalling clones (e.g. the 9-18
truncation).
Analysis of stalling levels with mutant ribosomes reveals nucleotides that
are required for efficient stalling on FxxYxIWPP peptides. A2058 is near the
L4/L22 constriction; the A2058G mutation reduces stalling at SecM by nearly 80fold, but it actually increases stalling on the WPPPSI clone by eight-fold. This
increased stalling efficiency on A2058G ribosomes has also been observed with
TnaC when wild-type ribosomes are also present in the cells (29). Likewise,
mutation of U2609 has different effects on these three peptides. In TnaC, the
U2609C mutant completely abolished stalling while U2609A only affected it
partially (29). SecM stalling is more reduced by the A mutant, and stalling at
WPPPSI is reduced by either the C or A mutant equally. These data show that
the FxxYxIWPP peptide binds with the exit tunnel at similar sites and in a similar
mechanism as these other peptides, though the specifics of each interaction are
slightly different.
Given that these interactions between rRNA nucleotides and key residues
in the nascent peptides are the basis for stalling, it is difficult to explain how
stalling occurs during termination at the sequence WPPDV*. The exit tunnel
interactions must be lined up properly with the second Pro codon in the P site
and Asp-tRNA in the A site. How then is termination inhibited when the
peptide has moved two amino acids further into the tunnel, with peptidyltRNAVal in the P site and RF2 in the A site? While we cannot answer this
question fully, we can state that the MS data definitively shows tagging after
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WPPDV, that the Asp residue is required for stalling but that the Val residue is
not, and that the stop codon must be one or two codons downstream from
WPPD for stalling to occur. It is tempting to speculate that this distance
limitation is due to plasticity of the peptide binding inside the exit tunnel.
We recognize that some peptides that induce stalling were missed in our
selection because they were either too long or incompatible with the structure
and activity of KanR. We were surprised that consecutive rare codons, known to
induce tagging, were not isolated in the selection. We demonstrated by
immunoblot that tagging does occur at SEPR* and SEPRRR, but these sequences
did not support KanR rescue by tmRNA. In the case of SEPR*, tagging is
probably at too low a level to support robust KanR activity. While SEPRRR
induces higher levels of tagging, the tag is probably not added with the precision
required to restore the KanR protein sequence properly. Alternatively, depletion
of low abundance tRNAs may be too taxing for cells. Immunoblot analysis of
tagging is performed after a brief period of strong overexpression. In contrast,
our genetic selection requires overexpression and tagging of KanR over long
periods of cell growth and division.
A second bias in our selection results is possible requirement for Pro at the
third position of the hexamer library. All three cases of selectants have Pro at
this position and stall with this Pro in the ribosomal P site. This may reflect the
length requirements of the loop before the KanR C-terminal helix; adding amino
acids to this loop may destabilize the protein structure. It seems likely that KanR
function requires Pro at this site; the corresponding residue in the natural KanR
sequence is Pro256.
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Like SecM and TnaC, WPP-containing sequences stall due to nascent
peptide interactions in the PTC and exit tunnel, with an effector bound in the A
site. This stalling involves inhibition of the peptidyl-transferase activity,
probably the result of conformational changes in the 23S rRNA as seen in the
cryo-EM reconstruction of ribosomes stalled on SecM. How might these
conformational changes inhibit ribosome function? Structural studies reveal that
residues U2506 and U2585 in the peptidyl-transferase center protect the peptidyltRNA from hydrolysis. These nucleotides are displaced upon the binding of the
incoming A-site tRNA, allowing the amino acid to enter and react. The PTC also
changes conformation as prompted by release factors to promote hydrolysis at
termination (31). A conformation that locks these nucleotides in place could
prevent both elongation and termination. SecM, TnaC, ErmCL, and FxxYxIWPP
peptides interact with different ligands (tRNAs or antibiotics) and different exit
tunnel features to achieve this common end. The lack of similarity in the
residues required for stalling in these peptides suggests that many solutions may
exist, and that regulation of gene expression by nascent peptides may be more
common than these few examples suggest.
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MATERIALS AND METHODS
DNA oligos were purchased from Sigma-Genosys or synthesized on a
BioAutomation MerMade 6 synthesizer. Enzymes were purchased from New
England Biolabs.

Plasmid Creation
Creation of the KanR tmRNA has been described previously (50).
Following validation of the selection on a two-plasmid system, the tmRNA-kanR
was cloned into the kanRΔ15-lib vector, to create pBAD-KT2. Randomized
library plasmids were created by PCR amplification using degenerate
oligonucleotide primers. Degenerate bases in the oligos were made from a mix
of 25% of dA, dT, dG, and dC phosphoramidites. PCR primers were Pep6:
CGAAAGGGTACCN18ATTACCATATTTTTGAAAAAGCCGTTTCTG and
Kan5: CATATGGCTAGCATGAGCCATATTCAACGGGAAAC.

Selection of stall peptide library
Library plasmids were ligated and introduced by electroporation into
DH10B cells, quantitated and grown in 500 mL overnight in ampicillin with
shaking at 37 °C. The amplified library was then introduced into X-90 ssrA::cat
by electroporation. After 30 minutes, ampicillin was added and kanRΔ15-lib was
induced for 2 hours with 2% arabinose. Cells were then plated on 2% ara, amp,
and 15 µg/mL kanamycin at 25 or 37 °C. Selectants were grown, sequenced and
recloned into fresh vector for verification. Testing of the recloned mutants in
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fresh cells is an important control to ensure that the colony is surviving because
of the altered peptide sequence and not a mutation elsewhere in the plasmid or
the cells.
The low stringency, constrained libraries were both done essentially the
same as the original library, but with the following reverse primers Vlib:
WPPNNV: AGACAAGGTACCN8BGGGGGGCCAAATACCAT
ATTTTTGAAAAAGCCGTTTCTG.
WPPVVV: AGACAAGGTACC(NNB)3N6AATACCAT
ATTTTTGAAAAAGCCGTTTCTG. The B mix consisted of equal volumes of dT,
dG, dC phosphoramidites.

Mass Spectrometry
The pGEX-3X vector (GE Healthsciences) was amplified with inverse PCR
to create NheI and PstI cloning sites and remove the C-terminal linker. The
library cassette +12 residues from kanR was PCR amplified with PstI and NheI
and cloned into the pGEX-3X vector to create pGEX-WPPP, WPPDV*, WPPWYR
vectors. X-90 cells bearing the plasmid pCH201 (tmRNA-H) were transformed
with each pGEX-WPP vector and grown overnight. Then, 500mL cultures were
inoculated to an OD600 = 0.05 and grown to OD600 = 0.5 and induced with 1 mM
IPTG for 2.5 h. Cells were pelleted for 20 min in a GS3 rotor at 4,000 rpm. Pellets
were resuspended in 20 mL B-PER (Thermo-scientific) and incubated with
stirring at 23 °C for 20 min. Cell lysate was cleared in an SS-34 rotor at 15,000
rpm for 20 min. Supernatant was incubated on ice then His-tagged GST was
directly loaded and purified at 4 °C on a Ni2+-NTA agarose resin (Qiagen). 50 µg
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of protein was acetone precipitated and digested with Trypsin (Promega) for 14
h with agitation at 37 °C. Tryptic fragments were purified in a Ni2+-NTA slurry
at 4 °C, protein was loaded on a reverse-phase ZipTip (Millipore) then spotted on
a MALDI-plate and overlayed with an alpha-CHC matrix (G2037A, Agilent
Technology). Samples were analyzed with a QSTAR Pulsar quadrupole
orthogonal time-of-flight mass spectrometer following MALDI and analyzed
with Analyst QS.

Immunoblot Assays
Each site-directed mutation for the immunoblot assays was cloned by
PCR as described above with the specific mutations incorporated in the forward
primer. The GST vector used for mass spectrometry sample preparation was
used as the backbone for all of these mutant vectors. pGEX-mutant plasmids
were transformed into X-90 ssrA::cat with tmRNA-H and grown overnight. 2 mL
cultures, diluted to OD600~0.1, were grown and induced at OD600~0.5 with 1mM
IPTG for 2-2.5 h then pelleted and frozen on dry ice. Samples were resuspended
in water and diluted 1:1 in SDS-lysis buffer and boiled 5 min. Lysates were
quantitated with DC Protein Assay (BioRad) and loaded equally on a 12% SDSPAGE gel and run in a Laemmli buffer for ~60 min at 200 V. Proteins were then
transferred to PVDF in a BioRad transfer apparatus at 300 mA at 4 °C.
Membrane was blocked 30 minutes in 5% milk–TBS then incubated overnight
with rocking at 4 °C in 20 mL 5% milk-TBS-tween with 1:1000 dilution of mouse
monoclonal anti-His6 (27E8 Cell Signaling Technology) and 1:1000 dilution of
rabbit monoclonal anti-GST antibodies (91G1 Cell Signaling Technology).
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Samples were rinsed and incubated 30 min in 5% milk-TBS-tween with 1:1000
dilution of both goat anti-mouse (LiCor IRDye 800CW) and goat anti-rabbit
(IRDye 680) secondary antibodies. Images were obtained on a Licor-Odyssey IR
scanner.

Miller Assays
Plasmids were created by ligating the same inserts from GST immunoblot
vectors after the ninth codon of full-length lacZ (derived from pNH122) (18).
AD16 cells (18) bearing a lacZ plasmid and a ribosomal mutant plasmid were
grown to saturation then diluted to OD600~0.1, grown to OD600~0.5 and induced
with 1mM IPTG for 40 min. 0.8 mL of cells was pelleted and resuspended in 1
mL Z-buffer with β-mercaptoethanol. Cells were lysed with 0.01% SDS and
chloroform then incubated at 30 °C with ONPG (4 mg/mL in 0.1 M phosphate
buffer, pH 7.0). The reaction was quenched with 1 M Na2CO3 and pelleted at
13,000 rpm for 10 min. The supernatant was removed and the OD420 was
recorded with a Beckman Coulter DU730 UV/Vis spectrophotometer.
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